Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003434	pf-prot	g/l (g/l)	5027	7192	0.11%
3003434	pf-prot	— (—)	742	869	100.00%	Distribution not available
3003434	pf-prot	g/l_______ (g/l)	86	110	0.00%
3003434	pf-prot	g/L (g/l)	22	27	0.00%
3003434	pf-prot	G/L (g/l)	16	19	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other heart diseases, wide

1158

1840

3.86

322.83

1.5

1.3

30.92

54.41

g/l

0.86

1035

1736

Bacterial pneumoniae

851

1743

4.41

317.40

1.5

1.4

32.22

33.03

g/l

0.92

748

1605

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

219

32.53

316.86

1.9

1.4

40.41

26.50

g/l

16.73

209

Other septicaemia, including avohilmo

964

2376

3.94

314.01

1.6

1.4

60.83

33.14

g/l

0.41

860

2165

Other heart diseases

592

566

6.92

313.17

1.5

1.3

31.34

39.76

g/l

30.40

519

529

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

645

1216

5.38

310.81

1.3

1.5

37.34

55.06

g/l

0.31

613

1071

Other septicaemia

947

2350

3.93

307.98

1.6

1.4

61.35

33.10

g/l

0.42

845

2141

Suppurative and necrotic conditions of lower respiratory tract

593

337

23.29

307.65

1.6

1.5

86.58

30.92

g/l

0.58

554

307

Non-ischemic cardiomyopathy

958

1382

5.79

307.65

1.5

1.4

28.40

58.23

g/l

0.81

834

1306

All kidney diseases

1546

3365

3.13

307.65

1.5

1.4

30.43

34.89

g/l

28.15

1365

3122

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1475

3830

3.44

307.65

1.6

1.4

34.18

40.07

g/l

0.34

1362

3450

Renal failure

1399

3142

3.95

307.65

1.6

1.4

27.15

43.19

g/l

1.04

1208

2884

Asthma, excluding more controls

654

185

18.37

307.65

1.5

1.1

33.37

30.44

g/l

2.08

599

166

Bacterial Sepsis

1252

2670

4.01

307.65

1.6

1.4

29.30

34.08

g/l

27.46

1103

2452

Other diseases of pleura

3543

1488

24.11

307.65

1.6

1.2

34.81

50.28

g/l

0.32

3340

1249

Pleural effusion

2642

564

73.21

307.65

1.7

1.2

35.83

27.75

g/l

37.77

2508

463

Asthma (only as main-diagnosis)

622

444

7.92

307.65

1.5

1.1

32.69

26.63

g/l

14.31

569

368

All chronic kidney diseases

1312

2754

3.92

307.65

1.6

1.4

27.64

34.31

g/l

53.14

1144

2552

Other bacterial diseases, including avohilmo

1786

2961

3.84

307.65

1.5

1.4

32.21

34.19

g/l

6.68

1622

2710

Heart failure and bmi 25plus

908

1149

5.50

307.65

1.6

1.4

28.43

63.33

g/l

0.77

797

1075

Bacterial infection, other or unspecified, including avohilmo

1537

2789

4.68

307.65

1.5

1.4

31.49

33.68

g/l

7.58

1395

2544

Other medical care

1555

2361

5.80

307.65

1.5

1.4

34.49

45.56

g/l

0.41

1464

2124

Renal tubulo-interstitial diseases

1657

3450

3.60

307.65

1.5

1.4

48.54

34.56

g/l

0.34

1453

3198

Lung cancer and mesothelioma

1020

272

35.33

307.65

1.5

1.1

38.37

25.85

g/l

42.44

967

220

Septicaemia

1067

2469

4.08

307.65

1.6

1.4

58.32

33.26

g/l

0.41

946

2248

Pyothorax

542

276

27.94

307.65

1.6

1.5

91.15

30.64

g/l

0.58

508

249

Explicit Sepsis

1085

2598

3.93

307.65

1.6

1.4

57.87

34.03

g/l

0.39

962

2386

Persons encountering health services for specific procedures and health care

1690

2880

3.52

307.65

1.5

1.4

33.22

43.96

g/l

0.51

1539

2601

Non-small cell lung cancer

499

621

8.69

307.65

1.4

1.5

38.39

27.85

g/l

48.54

474

540

ILD differential diagnosis

1029

449

11.69

307.65

1.5

1.1

34.02

26.66

g/l

22.89

943

371

All pneumoniae

2134

2546

5.59

307.65

1.5

1.4

33.36

33.75

g/l

0.52

1933

2331

Implicit bacterial Sepsis

1120

2540

3.92

307.65

1.6

1.4

28.93

33.88

g/l

27.08

991

2331

COPD (mode)

685

366

15.17

307.65

1.4

1.2

32.97

26.08

g/l

17.00

614

298

Heart failure, strict

1849

2350

5.75

307.65

1.6

1.4

27.27

49.38

g/l

1.12

1601

2200

Implicit bacterial Sepsis, including avohilmo

1177

2647

3.83

307.65

1.6

1.4

29.07

34.08

g/l

28.83

1033

2432

Bacterial infection, other or unspecified

1457

2746

4.65

307.65

1.5

1.4

31.31

33.52

g/l

7.45

1319

2504

Other bacterial diseases

1868

3164

4.00

307.65

1.5

1.4

31.72

34.15

g/l

10.19

1687

2889

Influenza and pneumonia

2073

2474

5.30

307.65

1.5

1.4

33.41

33.87

g/l

0.64

1880

2272

Asthma, unspecified (mode), excluding more controls

598

182

23.91

307.65

1.5

1.1

33.23

30.35

g/l

2.00

542

163

Implicit Sepsis

1412

3218

3.30

307.65

1.5

1.4

29.57

34.74

g/l

35.07

1250

2960

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1085

1173

8.26

307.65

1.5

38.29

55.47

g/l

0.29

1028

1037

Heart failure and antihypertensive medication

736

547

9.20

307.65

1.6

1.4

27.51

38.73

g/l

60.84

633

515

Non-small cell lung cancer, adenocarcinoma

353

320

12.54

307.65

1.4

1.5

38.89

27.63

g/l

31.76

335

282

COPD differential diagnosis

1030

449

11.70

307.65

1.5

1.1

34.00

26.66

g/l

22.83

944

371

Any death

1777

2099

6.20

307.65

1.5

1.4

33.19

48.37

g/l

0.54

1611

1908

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1679

3693

3.12

307.65

1.5

1.4

49.12

33.98

g/l

0.39

1493

3390

Pneumonia, organism unspecified

2061

2461

5.91

307.65

1.5

1.4

47.81

33.85

g/l

0.47

1877

2261

1862

2121

5.27

307.65

1.5

1.4

33.59

33.57

g/l

0.01

1692

1944

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1862

2121

5.27

307.65

1.5

1.4

33.59

33.57

g/l

0.01

1692

1944

Asthma

709

444

8.33

307.65

1.5

1.1

33.11

26.63

g/l

16.55

651

368

Malignant neoplasm of bronchus and lung, including Hilmo

863

1087

7.11

307.65

1.4

1.5

38.00

57.50

g/l

0.30

816

955

Heart failure and coronary heart disease

1244

2356

3.86

307.65

1.6

1.4

26.16

46.85

g/l

0.99

1070

2171

Pneumonias (Asthma/COPD co-morbidities)

2140

2549

5.63

307.65

1.5

1.4

33.40

33.74

g/l

0.45

1942

2331

Other pulmonary diagnosis

1054

446

12.06

307.65

1.5

1.1

33.87

26.66

g/l

22.05

965

369

Later onset COPD, excluding more controls

503

306

13.11

307.65

1.5

1.1

31.87

25.27

g/l

13.30

449

247

Asthma (only as main-diagnosis), excluding more controls

580

185

17.53

307.65

1.5

1.1

32.73

30.44

g/l

1.40

534

166

Malignant neoplasm of bronchus and lung

761

977

6.99

307.65

1.4

1.5

38.14

28.55

g/l

62.80

721

857

Asthma, unspecified (mode)

630

437

10.57

307.65

1.5

1.1

32.91

26.58

g/l

15.21

568

362

Explicit Sepsis, including avohilmo

1103

2621

3.94

307.65

1.6

1.4

57.43

34.06

g/l

0.39

978

2410

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2138

2591

5.65

307.65

1.5

1.4

33.39

33.68

g/l

0.36

1942

2367

Diseases of the respiratory system

757

444

8.68

307.65

1.5

1.2

33.09

28.23

g/l

9.79

686

370

Heart failure, not strict

1801

2079

6.04

307.65

1.6

1.3

29.40

52.23

g/l

0.99

1583

1967

All-cause Heart Failure

1802

2314

5.69

307.65

1.6

1.4

27.35

49.56

g/l

1.10

1561

2168

Asthma (mode)

646

449

7.64

307.65

1.5

1.1

32.89

26.66

g/l

15.14

599

371

Other pleural conditions

1474

351

61.27

307.65

1.8

1.2

35.08

26.90

g/l

23.72

1401

291

Malignant neoplasm of respiratory system and intrathoracic organs

983

1077

8.23

307.65

1.5

38.39

57.81

g/l

0.30

931

945

Excluding asthma or asthma-COPD overlap

1035

446

11.83

307.65

1.5

1.1

33.97

26.66

g/l

22.51

949

369

Abnormal findings on diagnostic imaging of lung

1276

3334

3.76

307.65

1.5

1.4

34.56

41.00

g/l

0.32

1179

3002

Oxycodone

1067

2177

4.35

307.65

1.5

1.4

35.84

31.49

g/l

20.09

1000

1937

Heart failure,strict

1663

1733

7.05

307.65

1.6

1.3

27.38

54.87

g/l

1.00

1447

1636

Dyspnoea

1843

3606

3.78

307.65

1.6

1.4

48.63

33.03

g/l

0.47

1695

3252

Non-small cell lung cancer, including Hilmo

670

863

7.90

307.65

1.4

1.5

38.63

28.35

g/l

62.50

633

753

Chronic kidney disease

961

2500

3.86

303.70

1.7

1.4

26.24

45.13

g/l

0.93

831

2282

Malignant neoplasm of heart, mediastinum and pleura

194

43.96

302.69

1.9

1.3

40.34

27.50

g/l

10.32

185

Bacterial pneumonia, not elsewhere classified

816

1680

4.39

302.52

1.5

1.4

32.08

32.91

g/l

0.92

717

1548

Early onset COPD, excluding more controls

299

245

12.52

302.29

1.4

1.2

34.84

27.67

g/l

10.45

268

201

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

535

928

6.07

295.62

1.3

1.5

38.23

28.96

g/l

41.38

507

820

Abnormalities of breathing

1317

2291

3.34

292.74

1.6

1.4

33.15

33.72

g/l

0.70

1204

2075

Implicit Sepsis, including avohilmo

1380

3247

3.09

291.27

1.5

1.4

29.81

34.87

g/l

33.21

1219

2993

Valvular heart disease excluding rheumatic fever

848

1429

4.34

289.84

1.6

1.4

28.49

58.83

g/l

0.86

756

1344

Non-rheumatic valve diseases

843

1427

4.32

286.19

1.6

1.4

28.49

58.85

g/l

0.86

752

1342

Dialysis, with operation codes

446

680

7.04

281.56

1.7

1.4

26.40

33.94

g/l

21.73

388

622

Mesothelioma, including Hilmo

183

41.69

280.20

2.0

1.4

40.70

27.54

g/l

11.24

174

Acute renal failure

693

1591

4.58

277.32

1.6

1.4

27.25

33.19

g/l

24.57

606

1445

Mesothelioma

173

50.23

271.11

2.0

1.3

40.57

27.25

g/l

10.14

165

Malignant neoplasm

1150

2022

3.38

262.97

1.4

1.5

35.13

46.12

g/l

0.32

1072

1788

Malignant neoplasm

1143

2020

3.36

259.36

1.4

1.5

35.20

46.12

g/l

0.32

1064

1786

Nephropathy related operations

434

701

6.66

259.29

1.7

1.4

26.29

32.91

g/l

16.47

379

633

Condition for Implicit Sepsis (Organ dysfunction codes)

1337

3202

2.94

257.26

1.5

1.4

29.87

35.00

g/l

32.78

1174

2961

Malignant neoplasm, including Hilmo

1137

2022

3.32

252.88

1.4

1.5

35.07

46.18

g/l

0.33

1054

1788

COPD/asthma related infections

1311

2121

3.14

252.86

1.5

1.4

32.82

33.57

g/l

1.05

1181

1944

COPD/asthma/ILD related infections

1311

2121

3.14

252.86

1.5

1.4

32.82

33.57

g/l

1.05

1181

1944

Malignant neoplasm, wide definition

1139

2030

3.31

252.22

1.4

1.5

35.07

46.13

g/l

0.33

1057

1795

Anaemias

258

21.57

251.42

1.6

1.4

30.85

41.88

g/l

9.77

230

Non-small cell lung cancer, adenocarcinoma, helper endpoint

353

482

8.28

249.33

1.4

1.5

38.89

31.07

g/l

21.34

335

431

Solid cancers

1116

2006

3.31

247.33

1.4

1.5

35.27

46.20

g/l

0.32

1044

1772

Liquid cancers, including Hilmo

720

1581

4.13

247.17

1.5

32.46

49.38

g/l

0.41

670

1387

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

277

285

10.67

243.55

1.7

1.5

38.74

27.78

g/l

25.43

263

249

Atrial fibrillation and flutter

477

473

6.66

242.92

1.5

1.3

30.03

39.46

g/l

34.20

432

442

Solid cancers, including Hilmo

1114

2023

3.25

240.23

1.4

1.5

35.18

46.13

g/l

0.32

1038

1788

Fever of other and unknown origin

985

2666

3.26

239.81

1.5

1.4

32.13

45.17

g/l

0.61

903

2432

Malignant neoplasm of mesothelium and soft tissue

226

178

14.55

238.66

1.8

1.5

38.61

28.40

g/l

16.00

214

157

Any event in cancer register

1147

2162

3.14

234.17

1.4

1.5

34.96

45.38

g/l

0.33

1064

1916

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1273

3081

2.83

227.57

1.5

1.4

30.42

35.26

g/l

28.29

1126

2857

Care involving dialysis

291

351

8.97

225.99

1.7

1.4

24.98

32.29

g/l

12.54

251

315

Pneumothorax

224

191

12.58

222.84

1.7

1.2

33.24

27.23

g/l

5.79

209

161

Erysipelas, including avohilmo

1122

2920

2.89

214.17

1.5

1.4

31.15

34.10

g/l

10.30

1008

2674

Any gastric operation

828

1100

3.82

211.59

1.5

1.4

32.62

33.07

g/l

0.36

755

998

GASTRO-related operations

828

1100

3.82

211.59

1.5

1.4

32.62

33.07

g/l

0.36

755

998

Atrial fibrillation and flutter with reimbursement

418

417

6.48

205.35

1.5

1.3

29.26

39.39

g/l

34.76

378

390

Cardiomyopathy

388

703

5.73

203.94

1.6

1.3

27.04

38.11

g/l

42.12

326

662

Diseases of arteries, arterioles and capillaries (FINNGEN)

380

407

6.60

198.37

1.6

1.3

29.68

39.40

g/l

26.44

342

378

Non-invasive ventilation

389

595

5.77

197.28

1.5

1.3

29.88

39.13

g/l

27.71

357

565

Liquid cancers

581

1432

3.95

191.86

1.6

1.5

31.84

51.15

g/l

0.42

544

1257

Aplastic and other anaemias

1018

3405

2.81

191.71

1.5

29.74

41.41

g/l

0.72

900

3094

Non-allergic asthma (mode), excluding more controls

154

17.99

189.81

1.5

1.1

31.91

31.04

g/l

0.21

141

Respiratory insufficiency

171

133

13.36

178.60

1.6

1.2

31.63

24.82

g/l

6.90

161

109

First line medication for Crohn's disease

1409

3183

2.41

172.65

1.5

1.4

33.73

42.14

g/l

0.42

1296

2862

Bacterial pneumonia (organism specified)

902

2957

2.83

172.35

1.5

32.33

32.23

g/l

0.08

796

2691

Erysipelas

911

2860

2.79

169.59

1.5

1.4

30.66

33.73

g/l

9.58

822

2606

Other anaemias

938

3298

2.73

168.50

1.5

29.81

41.57

g/l

0.70

831

2995

Other and unspecified anaemias

928

3288

2.72

165.28

1.5

29.80

41.59

g/l

0.70

821

2986

Cardiac arrhythmias

609

1066

3.70

164.79

1.5

1.3

30.88

38.49

g/l

33.19

554

1005

Ascites

277

470

6.34

157.75

1.6

1.4

33.28

32.30

g/l

0.49

249

430

Continuous positive airway pressure

332

517

5.50

157.49

1.5

1.4

30.70

39.27

g/l

19.69

264

489

Extracorporeal dialysis

237

350

7.40

155.02

1.7

1.5

25.43

32.31

g/l

9.48

203

315

Other disorders of fluid, electrolyte and acid-base balance

676

2160

3.03

147.26

1.5

1.4

29.41

46.90

g/l

0.68

599

1970

Secondary uncertain malignant neoplasm

320

658

5.07

146.40

1.6

1.5

34.30

28.20

g/l

13.26

311

569

Valvular operations

301

599

5.21

142.78

1.6

1.3

28.64

37.91

g/l

26.12

263

561

Cardiomyopathy (excluding other)

269

502

5.57

137.28

1.5

1.3

26.55

38.01

g/l

31.19

223

475

Acute tubulo-interstitial nephritis

907

3091

2.51

136.62

1.5

1.4

64.89

34.23

g/l

0.44

809

2868

Hypertensive heart and/or renal disease

575

1300

3.32

136.49

1.6

1.4

27.77

34.39

g/l

25.73

497

1195

COPD

898

2942

2.54

135.25

1.4

1.5

32.94

42.45

g/l

0.45

801

2666

Conduction disorders

478

1074

3.64

134.99

1.6

1.4

29.14

65.12

g/l

0.74

430

1021

Undetermined asthma, excluding more controls

105

18.68

132.33

1.5

1.1

34.69

29.51

g/l

1.74

Cardiomyopathies, Primary/intrinsic

255

476

5.56

130.10

1.5

1.3

26.32

37.86

g/l

29.95

210

451

Implicit viral Sepsis, including avohilmo

568

1885

3.08

129.77

1.6

1.4

29.71

33.71

g/l

10.36

499

1724

AV-block

358

732

4.30

128.58

1.7

1.3

28.32

77.59

g/l

0.67

325

692

Certain infectious and parasitic diseases

1077

2271

2.40

128.53

1.5

1.4

31.54

34.64

g/l

9.98

974

2081

Cardiovascular diseases (excluding rheumatic etc)

424

591

4.13

127.24

1.5

1.3

34.12

39.91

g/l

12.22

382

554

Oral corticosteroids

1366

3827

2.11

127.12

1.5

1.4

32.81

40.89

g/l

0.51

1253

3464

Other chronic obstructive pulmonary disease

864

2889

2.50

126.96

1.4

1.5

32.76

42.65

g/l

0.46

770

2618

Cerebrovascular diseases (FINNGEN)

327

483

4.81

126.71

1.6

1.3

31.96

39.38

g/l

15.85

295

452

ILD medications: prednisolone, methylprednisolone, prednisone

1352

3567

2.13

126.14

1.5

1.4

32.65

41.65

g/l

0.54

1236

3224

Haemorrhage from respiratory passages

608

1861

2.95

125.75

1.5

1.4

80.50

32.97

g/l

0.47

549

1676

Diseases of arteries, arterioles and capillaries

1120

3736

2.23

125.23

1.5

28.84

41.43

g/l

0.93

990

3403

Presence of cardiac and vascular implants and grafts

885

2691

2.47

123.61

1.6

1.5

27.99

44.79

g/l

0.87

789

2444

Malaise and fatigue

799

2496

2.56

122.92

1.5

1.4

30.43

45.75

g/l

0.69

709

2272

Other arrhythmias

653

1730

2.85

122.62

1.6

1.3

30.79

55.20

g/l

0.83

598

1633

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

312

726

4.45

122.41

1.5

33.58

28.98

g/l

7.76

296

637

Codes for special purposes

820

3413

2.42

117.66

1.5

1.4

31.93

41.74

g/l

0.57

742

3096

Provisional assignment of new diseases of uncertain etiology

819

3410

2.42

117.46

1.5

1.4

31.94

41.74

g/l

0.57

741

3094

Glomerular disorders in diseases classified elsewhere

305

726

4.40

116.79

1.6

1.5

26.14

32.44

g/l

12.53

264

655

Other chronic obstructive pulmonary disease, including avohilmo

965

3533

2.28

116.37

1.4

1.5

33.04

40.79

g/l

0.44

859

3208

Glomerular diseases

400

1154

3.59

116.15

1.6

1.5

26.21

32.46

g/l

15.21

345

1049

Covid-19 confirmed case

696

2735

2.60

115.54

1.5

31.41

32.21

g/l

0.88

629

2477

Tramadol

948

2455

2.35

113.87

1.5

1.4

64.74

32.05

g/l

0.51

858

2194

Malignant neoplasm of breast, HER2-negative

401

688

3.81

113.10

1.3

1.4

35.00

29.50

g/l

11.78

377

601

Implicit viral Sepsis

415

1246

3.42

112.85

1.6

1.4

29.10

33.18

g/l

8.01

369

1134

Viral Sepsis

415

1246

3.42

112.84

1.6

1.4

29.10

33.18

g/l

8.01

369

1134

Unspecified kidney failure

302

733

4.33

112.82

1.5

1.4

26.66

31.91

g/l

9.36

253

664

Malignant neoplasm of breast

400

688

3.80

112.40

1.3

1.4

35.00

29.50

g/l

11.78

377

601

ILD medications

1343

3574

2.04

112.20

1.6

1.4

32.80

41.67

g/l

0.53

1227

3230

Pleural plaque

211

381

5.79

111.89

1.5

1.2

35.46

26.65

g/l

16.55

199

306

Allergic asthma (mode), excluding more controls

105

13.75

111.78

1.4

1.1

32.73

32.85

g/l

0.02

100

COPD, early/later onset

877

3225

2.33

110.97

1.4

1.5

32.79

41.55

g/l

0.46

781

2930

COPD, hospital admissions

869

3208

2.33

110.01

1.4

1.5

32.88

41.58

g/l

0.45

776

2914

Malignant neoplasm of breast, HER2-negative, including Hilmo

399

691

3.75

109.83

1.3

1.4

34.83

29.51

g/l

11.05

376

603

Malignant neoplasm of breast, including Hilmo

399

691

3.75

109.81

1.3

1.4

34.83

29.51

g/l

11.05

376

603

malignant neoplasm of female genital organs, including Hilmo

255

517

4.82

109.79

1.3

1.4

37.81

28.43

g/l

20.86

237

448

Complications of surgical and medical care, not elsewhere classified

1287

4293

2.02

109.77

1.5

1.4

31.50

40.31

g/l

0.68

1168

3898

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1159

3505

2.11

109.53

1.5

1.4

30.95

43.14

g/l

0.81

1042

3201

Pulmonary heart disease, diseases of pulmonary circulation

634

2450

2.65

109.48

1.4

1.5

80.40

31.79

g/l

0.53

588

2202

Hypertensive Heart Disease

499

1248

3.11

108.16

1.6

1.4

28.09

34.32

g/l

20.87

430

1149

COPD related to multimorbidity

804

2939

2.37

105.18

1.5

32.12

42.25

g/l

0.49

714

2672

Hypertensive diseases (excluding secondary)

375

566

3.89

104.90

1.6

1.3

33.44

39.72

g/l

12.76

333

529

Bleeding

1162

4012

2.05

104.74

1.5

1.4

56.54

33.67

g/l

0.41

1036

3651

Non-allergic asthma (mode)

154

213

7.26

103.81

1.5

1.2

31.91

26.16

g/l

4.92

141

174

Symptoms and signs involving the circulatory and respiratory systems

1014

2293

2.23

103.80

1.5

1.4

32.53

33.72

g/l

1.82

919

2077

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

343

542

4.02

103.49

1.5

1.3

32.80

39.38

g/l

12.31

313

507

Transplanted organ and tissue status

218

435

5.23

103.44

1.6

1.4

27.34

34.59

g/l

12.33

195

394

Malignant neoplasm of ovary, including Hilmo

133

162

8.60

101.95

1.2

1.4

39.22

27.28

g/l

14.42

126

138

Inflammatory bowel disease treatment related agents

1348

3840

1.96

101.92

1.5

1.4

32.86

40.91

g/l

0.51

1232

3476

Pericarditis

108

100

11.55

101.82

1.5

1.3

34.77

37.71

g/l

1.23

Diabetic nephropathy, excluding more controls

349

789

3.75

101.62

1.6

1.4

27.12

32.37

g/l

9.84

303

710

Metabolic disorders

1142

3345

2.07

101.25

1.5

1.4

31.31

42.99

g/l

0.71

1027

3060

Opioids

1039

2483

2.18

101.15

1.5

1.4

33.85

32.21

g/l

3.27

957

2220

Malignant neoplasm of breast, HER-positive

334

654

3.86

100.78

1.4

35.73

29.50

g/l

13.29

313

573

Paroxysmal tachycardia

238

410

4.89

100.39

1.6

1.3

29.71

39.36

g/l

20.20

209

386

Malignant neoplasm of breast, ER-positive, including Hilmo

334

655

3.85

100.36

1.4

35.73

29.52

g/l

13.21

313

574

Percutaneous Coronary Intervention

1004

2866

2.15

99.06

1.5

1.4

29.80

45.79

g/l

0.91

900

2649

Any reimbursement code in KELA

365

464

3.97

98.72

1.5

1.3

33.74

100.97

g/l

0.53

330

429

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

13.67

98.68

1.3

1.4

40.49

28.38

g/l

8.82

Infections, IBD-co-morbidities

277

444

4.49

98.57

1.6

1.3

30.11

35.58

g/l

7.26

249

406

Pacemaker

758

3095

2.33

97.63

1.6

1.5

27.55

42.13

g/l

0.86

669

2797

All influenza

361

1086

3.38

97.45

1.5

1.4

30.23

32.77

g/l

2.97

319

998

COPD, hospital admission 2, with asthma infections

676

2423

2.46

96.83

1.4

1.5

32.85

31.79

g/l

1.30

601

2192

Adjustment and management of implanted device

383

1221

3.23

94.71

1.7

1.4

28.94

31.19

g/l

3.22

330

1078

General symptoms and signs

1140

2812

2.05

94.11

1.5

1.4

32.25

44.75

g/l

0.62

1041

2567

Pulmonary embolism

561

2202

2.61

93.90

1.4

1.5

87.30

31.83

g/l

0.53

520

1974

COPD, hospital admissions 3, with asthma pneumonia sepsis

611

2113

2.55

93.68

1.4

1.5

32.72

31.39

g/l

1.72

543

1906

Venous thromboembolism

865

3934

2.15

93.26

1.4

1.5

68.59

32.09

g/l

0.54

793

3556

Coronary revascularization (ANGIO or CABG)

987

2866

2.11

92.99

1.5

1.4

29.69

45.79

g/l

0.92

885

2649

Emergency coronary revascularization (for ACS)

1115

3375

2.02

92.45

1.5

1.4

29.61

43.43

g/l

0.93

992

3105

Secondary hypertension

139

195

7.25

92.27

1.5

1.3

26.52

39.20

g/l

16.18

113

182

Pulmonary heart disease

561

2222

2.58

92.16

1.4

1.5

87.30

31.74

g/l

0.53

520

1995

malignant neoplasm of female genital organs

222

480

4.64

92.11

1.3

1.4

38.07

28.05

g/l

21.28

206

415

Non-Hodgkin lymphoma, all, including Hilmo

255

634

4.16

91.79

1.6

1.5

31.29

28.63

g/l

2.63

245

549

Malignant neoplasm of digestive organs, including Hilmo

579

1667

2.59

90.24

1.4

1.5

31.96

48.56

g/l

0.42

529

1462

DVT of lower extremities and pulmonary embolism

716

3181

2.28

89.75

1.4

1.5

75.85

31.99

g/l

0.53

656

2874

Peripheral artery disease

830

3058

2.19

89.26

1.5

27.77

42.69

g/l

0.89

719

2786

Iron deficiency anaemia

704

3073

2.28

88.44

1.5

1.4

28.84

32.61

g/l

11.70

625

2781

Complications of procedures, not elsewhere classified

1030

4210

1.99

87.97

1.5

1.4

31.52

40.44

g/l

0.67

942

3821

Asthma-related pneumonia

642

2753

2.37

87.70

1.4

1.5

32.20

32.06

g/l

0.10

577

2482

Asthma, hospital admissions 3, pneumonia

642

2757

2.36

87.40

1.4

1.5

32.20

32.05

g/l

0.10

577

2486

Asthma-related pneumonia or sepsis

642

2757

2.36

87.40

1.4

1.5

32.20

32.05

g/l

0.10

577

2486

Viral pneumonia

223

520

4.41

87.22

1.7

1.4

168.63

32.07

g/l

0.49

198

481

Dialysis

120

157

8.19

87.14

1.6

1.5

22.70

34.18

g/l

12.64

101

141

L04AD Calcineurin inhibitors

199

434

4.74

84.87

1.7

1.5

27.40

33.42

g/l

7.97

179

394

Hyperkalaemia

190

402

5.02

84.80

1.6

1.4

25.78

31.66

g/l

7.12

168

366

Primary_lymphoid and hematopoietic malignant neoplasms

473

1799

2.70

84.69

1.6

1.5

31.72

32.08

g/l

0.25

448

1603

Explicit bacterial Sepsis, including avohilmo

239

602

4.11

84.61

1.5

1.4

30.87

32.56

g/l

1.10

206

551

Other CVD (FINNGEN)

183

262

5.47

83.70

1.7

1.3

30.61

38.71

g/l

11.53

163

247

Hard cardiovascular diseases

951

2753

2.06

83.45

1.5

1.4

30.46

46.34

g/l

0.85

853

2547

L01XE Protein kinase inhibitors

164

311

5.65

83.23

1.4

1.5

36.11

32.24

g/l

3.47

157

281

Polyarthropathies

913

2865

2.07

82.51

1.5

1.4

31.42

43.95

g/l

0.62

835

2588

Neoplasms

615

1295

2.51

82.34

1.5

1.4

34.51

55.34

g/l

0.42

565

1161

Ischemic heart diseases

974

2893

2.02

81.59

1.5

1.4

30.18

45.70

g/l

0.88

865

2673

Explicit bacterial Sepsis

233

594

4.06

81.15

1.5

1.4

30.84

32.44

g/l

0.98

201

544

Major coronary heart disease event

1024

3123

1.98

80.93

1.5

1.4

29.62

44.65

g/l

0.94

915

2883

Complications of medical and surgical care

959

4430

1.97

80.64

1.5

1.4

31.44

39.85

g/l

0.66

867

4021

ILD medications: immunosuppressive drugs

714

2999

2.18

79.40

1.5

1.4

32.59

43.77

g/l

0.57

657

2721

Ulcer of lower limb, not elsewhere classified

344

1146

3.11

79.25

1.6

1.5

28.20

31.49

g/l

4.56

291

1036

Caries of dentine

392

1342

2.88

79.20

1.5

32.22

33.54

g/l

1.10

342

1210

Cardiovascular diseases

332

502

3.53

79.06

1.5

1.3

34.11

39.89

g/l

9.63

300

470

Other diseases of the respiratory system

432

1636

2.71

78.14

1.6

1.5

31.28

31.23

g/l

0.03

402

1457

Other respiratory disorders and diseases

432

1636

2.71

78.14

1.6

1.5

31.28

31.23

g/l

0.03

402

1457

Atherosclerosis, excluding cerebral and coronary sclerosis

782

2951

2.12

78.00

1.5

27.67

42.92

g/l

0.87

683

2686

Nutritional anaemias

782

3626

2.09

77.96

1.5

1.4

28.98

40.99

g/l

0.83

697

3298

Malignant neoplasm of digestive organs

526

1624

2.51

77.90

1.4

1.5

31.94

48.78

g/l

0.42

478

1427

Streptococcal septicaemia, including avohilmo

214

531

4.19

77.54

1.5

1.4

31.21

32.28

g/l

0.52

183

484

Dental caries

424

1496

2.73

77.18

1.5

32.12

33.39

g/l

1.12

371

1355

Insulin medication

842

3477

2.03

76.64

1.6

1.4

29.27

41.85

g/l

0.84

744

3174

Streptococcal septicaemia

208

515

4.20

75.60

1.5

1.4

31.19

32.20

g/l

0.47

178

469

Cardiomyopathy, other and unspecified

145

268

5.61

74.95

1.6

1.3

28.45

37.39

g/l

10.27

120

257

Type 2 diabetes, wide definition

991

3257

1.94

74.51

1.5

1.4

31.24

43.17

g/l

0.71

885

2990

Abscess of lung

11.80

74.26

1.3

1.5

36.95

30.92

g/l

2.82

Calcific aortic valvular stenosis, operated

619

2721

2.24

73.38

1.6

1.4

27.65

31.80

g/l

13.83

548

2451

Calcific aortic valvular stenosis

619

2721

2.24

73.38

1.6

1.4

27.65

31.80

g/l

13.83

548

2451

Undetermined asthma

105

142

7.49

73.11

1.5

1.2

34.69

25.43

g/l

7.68

117

Operations 2 for CAVS

618

2721

2.24

72.96

1.6

1.4

27.65

31.80

g/l

13.83

548

2451

Calcific aortic valvular stenosis, diagnosis (helper)

618

2721

2.24

72.96

1.6

1.4

27.65

31.80

g/l

13.83

548

2451

Calcific aortic valvular stenosis, including rheumatic fever

618

2731

2.23

72.09

1.6

1.4

27.65

31.79

g/l

13.75

548

2460

Pain in throat and chest

795

2283

2.08

71.57

1.4

32.62

33.68

g/l

1.36

709

2068

Care involving use of rehabilitation procedures

654

2756

2.15

70.79

1.5

1.4

30.56

44.25

g/l

0.67

582

2489

Hypo-osmolality and hyponatraemia

346

1227

2.87

69.81

1.6

1.4

30.97

32.31

g/l

1.03

307

1108

Malignant neoplasm of skin, including Hilmo

593

1753

2.29

69.75

1.4

1.5

31.63

47.76

g/l

0.44

536

1545

Coronary atherosclerosis

842

2681

2.00

69.54

1.5

1.4

29.36

46.33

g/l

0.90

749

2473

ILD, hospital admissions 3, with pneumonia sepsis

186

451

4.29

69.54

1.5

1.4

32.55

31.36

g/l

0.56

162

414

Hypertension, essential

727

1943

2.13

69.13

1.5

1.4

32.24

35.60

g/l

8.40

653

1791

Myocardial infarction

716

2408

2.11

69.06

1.5

1.4

29.29

47.34

g/l

0.84

627

2217

Hernia of abdominal wall, postoperative

215

573

3.78

69.03

1.4

32.37

32.89

g/l

0.22

196

525

Malignant neoplasm of skin

577

1716

2.30

68.78

1.5

31.63

48.08

g/l

0.44

522

1512

Oedema, not elsewhere classified

479

1966

2.42

68.76

1.5

1.4

30.39

48.85

g/l

0.64

418

1782

Major coronary heart disease event excluding revascularizations

831

2791

1.99

67.86

1.5

1.4

29.25

45.47

g/l

0.89

730

2565

Diabetic nephropathy

353

1283

2.81

67.70

1.6

1.5

27.01

31.38

g/l

7.89

307

1146

Gout

562

2181

2.26

66.71

1.6

1.4

28.73

46.47

g/l

0.69

503

1956

Other disorders of skin and subcutaneous tissue

950

4368

1.85

66.34

1.5

1.4

30.60

39.99

g/l

0.76

846

3974

ILD, hospital admission 2, with pulmonary infections

195

508

3.97

65.99

1.5

1.4

32.57

31.39

g/l

0.58

168

467

Nonischemic cardiomyopathy

216

605

3.70

65.81

1.5

1.4

27.84

33.78

g/l

8.92

183

559

Other and unspecified iron deficiency

532

2386

2.26

65.73

1.6

1.5

29.20

32.40

g/l

6.75

473

2148

Certain infectious and parasitic diseases, including avohilmo

732

1757

2.10

65.16

1.6

1.4

31.52

34.66

g/l

7.75

657

1619

Other dialysis

101

154

7.09

64.19

1.6

1.5

22.20

32.23

g/l

8.66

140

Gout, FINNGEN

562

2595

2.20

64.12

1.6

1.5

28.73

43.82

g/l

0.70

503

2339

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

557

1679

2.26

63.93

1.4

1.5

31.83

48.29

g/l

0.43

503

1478

Basal cell carcinoma, including Hilmo

548

1648

2.28

63.84

1.4

1.5

31.81

48.53

g/l

0.42

492

1449

Hypertensive diseases

715

1959

2.07

63.46

1.6

1.4

32.62

35.60

g/l

6.69

642

1807

Hypertension

714

1959

2.07

63.12

1.5

1.4

32.63

35.60

g/l

6.63

641

1807

STROKE

598

1867

2.18

62.60

1.5

1.4

31.78

52.37

g/l

0.72

542

1738

Codeine

872

2465

1.92

62.39

1.5

1.4

32.84

32.21

g/l

0.69

809

2204

Allergic asthma (mode)

105

164

6.29

61.93

1.4

1.2

32.73

27.94

g/l

2.85

100

139

Other malignant neoplasms of skin (=non-melanoma skin cancer)

541

1644

2.26

61.89

1.4

1.5

31.65

48.54

g/l

0.43

489

1445

Basal cell carcinoma

531

1617

2.27

61.20

1.4

1.5

31.71

48.79

g/l

0.42

477

1421

Hypothyroidism (congenital or acquired)

115

7.53

60.73

1.6

1.4

34.30

43.04

g/l

5.78

108

Insulin, combination of fast acting with intermediate-acting or long-acting

843

4151

1.86

60.41

1.6

1.4

29.27

40.30

g/l

0.89

744

3781

Later onset COPD

591

2269

2.14

60.40

1.5

31.70

31.29

g/l

0.32

526

2044

Chronic lower respiratory diseases

1262

3934

1.70

60.01

1.5

1.4

33.09

40.71

g/l

0.49

1146

3575

Depression medications

124

7.12

59.14

1.7

1.4

36.51

43.27

g/l

3.95

110

Cardiodefibrillation

613

3046

2.04

58.17

1.6

1.5

28.60

42.57

g/l

0.80

532

2767

Hypothyroidism, levothyroxine purchases

111

7.36

57.71

1.6

1.4

34.63

42.94

g/l

5.20

104

Hypothyroidism and >3 levothyroxin purchases

111

7.36

57.71

1.6

1.4

34.63

42.94

g/l

5.20

104

Preparatory care for dialysis

129

275

5.00

57.30

1.7

1.5

24.81

32.08

g/l

6.66

108

248

Autoimmune diseases excluding thyroid diseases, strict definition

1106

3530

1.71

54.83

1.5

1.4

31.99

41.90

g/l

0.61

994

3208

Non-small cell lung cancer, squamous

130

288

4.73

54.82

1.4

36.05

27.26

g/l

13.15

123

257

Insulin, intermediate and long-acting

748

3915

1.86

54.42

1.6

1.4

29.01

40.75

g/l

0.89

658

3565

Asthma, hospital admission 2, infections

725

3800

1.88

54.23

1.4

32.61

32.89

g/l

0.24

650

3451

Asthma-related infections

725

3800

1.88

54.23

1.4

32.61

32.89

g/l

0.24

650

3451

Autoimmune diseases excluding thyroid diseases

1135

3647

1.70

54.16

1.5

1.4

31.91

41.55

g/l

0.61

1020

3318

Type 1 diabetes

308

1187

2.63

53.39

1.5

1.4

26.89

34.03

g/l

16.12

268

1094

Insulin, fast-acting

485

2283

2.15

53.35

1.7

1.4

27.58

33.14

g/l

16.42

426

2072

Other diseases of blood and blood-forming organs, wide

338

1374

2.51

52.81

1.5

33.96

32.36

g/l

1.43

305

1245

Peripheral arterial reconstruction

364

1545

2.42

52.05

1.5

27.78

31.38

g/l

5.58

312

1378

Amputation

230

778

3.06

51.79

1.6

1.4

27.37

31.43

g/l

4.47

192

701

Disorders of lipoprotein metabolism and other lipidaemias

934

3255

1.76

51.69

1.5

1.4

31.81

43.09

g/l

0.66

837

2978

Gout, idiopatic and unspecified

470

2223

2.16

51.57

1.6

1.5

28.71

32.39

g/l

8.33

416

2011

Parasetamol

669

1717

1.98

51.33

1.5

1.4

32.63

32.88

g/l

0.18

611

1547

L04AA Selective immunosuppressants

284

1077

2.68

51.14

1.6

1.5

30.92

33.63

g/l

2.79

258

975

Diabetes, varying definitions

1005

3429

1.71

50.07

1.5

1.4

31.42

42.84

g/l

0.72

902

3148

COPD-related respiratory insufficiency

257

945

2.81

49.66

1.4

1.5

30.63

31.38

g/l

0.43

225

840

Myocardial infarction, strict

634

2336

1.94

49.56

1.5

1.4

29.21

47.64

g/l

0.83

553

2148

Implicit fungal Sepsis, including avohilmo

139

351

4.10

49.29

1.6

1.5

29.26

33.54

g/l

3.19

126

325

Diabetes mellitus

1005

3432

1.70

49.16

1.5

1.4

31.40

42.84

g/l

0.72

903

3151

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

750

4121

1.80

49.16

1.4

31.44

40.38

g/l

0.65

674

3743

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

195

405

3.46

49.16

1.5

1.3

33.43

35.45

g/l

1.16

167

370

Kidney transplant status

102

202

5.25

49.05

1.7

1.5

24.22

34.09

g/l

9.17

182

Malignant neoplasm of urinary organs, including Hilmo

189

588

3.30

48.90

1.5

32.66

28.05

g/l

5.34

174

515

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

272

1040

2.69

48.53

1.7

1.5

140.43

32.85

g/l

0.47

244

940

Coronary artery bypass grafting

458

1593

2.17

48.30

1.5

29.12

52.71

g/l

0.69

392

1470

Type 1 diabetes, wide definition, subgroup 1

241

867

2.82

47.92

1.6

1.4

26.38

34.55

g/l

15.33

206

802

Type 2 diabetes

992

3413

1.69

47.71

1.5

1.4

31.48

42.86

g/l

0.71

892

3133

Fungal Sepsis

102

209

5.12

47.30

1.6

1.5

29.63

33.06

g/l

1.58

191

Cirrhosis of liver, NAS

133

337

4.14

47.21

1.7

1.5

27.06

32.18

g/l

3.84

120

304

Enterocolitis due to Clostridium difficile

216

744

2.99

47.06

1.6

1.5

26.62

31.04

g/l

5.45

190

671

Intestinal infectious diseases

1014

4588

1.65

46.88

1.5

1.4

30.38

40.11

g/l

0.85

917

4166

COPD, hospital admissions 1, only main diagnosis

593

2687

1.93

46.62

1.4

1.5

32.56

31.84

g/l

0.72

535

2427

Other bacterial intestinal infections

297

1207

2.51

46.54

1.6

1.5

27.90

32.21

g/l

6.84

264

1086

Ischaemic heart disease, wide definition

887

3189

1.73

46.23

1.5

1.4

30.21

44.15

g/l

0.86

792

2927

Peripheral artery operations in Hilmo

260

997

2.68

46.13

1.6

1.4

27.58

31.92

g/l

5.55

221

895

Insulin, fast-acting or short human

487

2427

2.03

46.05

1.7

1.4

27.57

32.97

g/l

15.75

428

2197

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

254

431

2.97

46.05

1.4

1.3

32.75

35.82

g/l

2.40

225

385

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

958

3400

1.68

45.25

1.5

1.4

31.77

42.90

g/l

0.69

856

3121

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

168

511

3.38

45.15

1.5

32.84

28.49

g/l

4.37

155

446

Gout, strict definition

359

1611

2.28

45.13

1.6

1.5

28.12

32.35

g/l

8.43

315

1449

Pure hypercholesterolaemia

859

3197

1.72

44.49

1.5

1.4

32.24

43.20

g/l

0.61

779

2924

Cough

417

1845

2.13

44.45

1.5

1.4

33.96

33.46

g/l

0.34

388

1678

Fibrosis and cirrhosis of liver

159

475

3.47

44.17

1.7

1.5

27.76

32.70

g/l

4.34

142

428

Implicit fungal Sepsis

191

5.16

44.05

1.6

1.5

29.49

33.08

g/l

1.58

174

Diseases of oesophagus, stomach and duodenum

1108

4093

1.61

43.86

1.5

1.4

31.55

33.40

g/l

4.67

994

3737

Dipeptidyl peptidase 4 (DPP-4) inhibitors

770

3491

1.75

43.86

1.6

1.4

30.98

41.35

g/l

0.64

684

3176

Iron deficiency anaemia secondary to blood loss (chronic)

272

1093

2.54

43.75

1.5

27.63

31.28

g/l

4.71

245

977

Antihypertensive medication - note that there are other indications

335

714

2.46

43.68

1.6

1.3

32.75

39.35

g/l

14.12

302

673

Disorders resulting from impaired renal tubular function

198

5.07

43.33

1.7

1.5

25.60

32.03

g/l

4.36

181

Infections of the skin and subcutaneous tissue

632

3443

1.82

43.18

1.5

1.4

79.02

33.58

g/l

0.47

582

3115

Invasive ventilation

143

405

3.65

43.10

1.5

30.32

31.90

g/l

0.61

127

366

Diseases of liver

448

2230

2.03

42.65

1.7

1.4

97.62

33.62

g/l

0.46

402

2030

Gout, unspecified

380

1788

2.17

42.41

1.6

1.5

28.16

32.34

g/l

8.58

335

1607

Bacterial intestinal infections, IBD co-morbidities

293

1237

2.41

42.28

1.6

1.5

27.77

31.84

g/l

6.11

261

1105

Agranulocytosis

180

594

3.11

42.26

1.5

35.41

32.74

g/l

2.11

164

539

Malignant neoplasm, without specification of site, including Hilmo

101

226

4.64

42.00

1.4

37.72

26.66

g/l

15.91

199

Amputation of toe

170

548

3.23

41.87

1.6

1.5

27.23

31.07

g/l

3.10

142

496

Type 1 diabetes, wide definition

249

978

2.58

41.68

1.6

1.4

26.51

34.09

g/l

14.32

214

901

Malignant neoplasm of urinary organs

161

505

3.27

41.20

1.5

32.91

28.33

g/l

4.52

147

442

Chronic lymphocytic leukaemia, helper endpoint

141

5.77

40.61

1.6

1.5

29.65

27.76

g/l

0.58

123

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

141

5.77

40.61

1.6

1.5

29.65

27.76

g/l

0.58

123

Chronic lymphocytic leukaemia

141

5.77

40.61

1.6

1.5

29.65

27.76

g/l

0.58

123

Enlarged lymph nodes

213

786

2.76

40.60

1.6

1.4

32.87

33.30

g/l

0.20

202

708

Morphin

135

5.94

40.41

1.9

1.5

36.17

27.94

g/l

5.95

116

Diarrhoea and gastroenteritis of presumed infectious origin

742

3900

1.71

40.29

1.5

1.4

30.70

33.52

g/l

7.05

675

3538

Diseases of the digestive system

635

3584

1.78

39.93

1.6

1.4

28.78

41.04

g/l

0.83

569

3250

Malignant neoplasm of kidney, except renal pelvis

147

449

3.36

39.32

1.4

1.5

33.11

28.28

g/l

4.61

135

391

Other bacterial intestinal infections, including avohilmo

327

1495

2.22

39.05

1.6

1.5

28.03

32.54

g/l

8.19

289

1351

Endocrine, nutritional and metabolic diseases

639

1772

1.83

39.00

1.6

1.4

32.24

52.02

g/l

0.63

573

1648

Other respiratory diseases principally affecting the interstitium

326

1497

2.23

38.75

1.5

32.04

31.14

g/l

0.59

285

1342

Acute peritonitis

133

386

3.57

38.73

1.6

1.5

27.63

31.42

g/l

2.32

120

350

Myocardial infarction, without ST-elevation

656

3429

1.75

38.27

1.5

28.22

41.14

g/l

0.84

576

3114

Medicines for HER+ breast cancer

363

1613

2.12

38.24

1.4

35.52

32.76

g/l

4.38

340

1472

Dilated cardiomyopathy

224

878

2.62

38.22

1.5

25.99

32.14

g/l

10.23

185

792

Substance abuse, excluding more controls

644

3086

1.76

38.14

1.5

80.18

33.26

g/l

0.50

584

2807

Diabetes, insulin treatment (Kela reimbursement)

1047

3982

1.57

38.09

1.5

1.4

31.58

41.10

g/l

0.68

934

3638

Vocal cord dysfunction

146

390

3.34

37.91

1.5

1.4

33.91

39.32

g/l

5.09

133

375

681

3573

1.72

37.41

1.5

77.60

33.13

g/l

0.49

606

3243

Hypertensive Renal Disease

241

4.31

37.19

1.6

1.4

25.73

33.20

g/l

5.35

230

Osteopathies and chondropathies

641

3401

1.74

36.93

1.5

1.4

30.97

33.22

g/l

4.48

561

3097

Cardiac arrest

179

4.56

36.85

1.5

1.3

27.24

39.31

g/l

11.96

167

GI-bleeding

501

2731

1.86

36.51

1.6

1.4

28.22

32.22

g/l

9.64

448

2458

Persons encountering health services in other circumstances, wide

1185

4014

1.52

36.46

1.6

1.4

58.08

33.08

g/l

0.48

1073

3649

Syncope and collapse

527

2410

1.84

36.44

1.5

1.4

30.73

45.97

g/l

0.65

471

2193

Fall on same level

1083

3745

1.55

36.06

1.5

1.4

60.22

33.70

g/l

0.46

981

3406

Other diseases of the digestive system

497

2715

1.86

36.00

1.6

1.4

28.27

32.22

g/l

9.48

444

2444

Cerebrovascular diseases

914

4023

1.59

35.49

1.5

30.42

40.68

g/l

0.77

806

3667

Mental and behavioural disorders due to psychoactive substance use

664

3607

1.70

35.39

1.5

78.78

33.12

g/l

0.50

601

3268

Volume depletion

181

662

2.80

35.38

1.6

1.5

27.36

31.38

g/l

4.31

165

599

Heart failure and hypertrophic cardiomyopathy

122

5.88

34.79

1.8

1.5

25.27

31.04

g/l

2.68

109

Disorders of lens

756

2842

1.66

34.61

1.5

1.4

30.52

44.99

g/l

0.76

681

2581

Use of hypnotics and sedatives

1082

4065

1.53

34.50

1.4

1.5

60.72

32.95

g/l

0.51

998

3673

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

670

4019

1.68

34.41

1.4

1.5

31.46

40.34

g/l

0.62

605

3655

Substance abuse

644

3550

1.70

34.37

1.5

80.18

33.10

g/l

0.50

584

3216

Hyperlipidaemia, other/unspecified

530

2676

1.80

34.34

1.5

1.4

30.57

44.48

g/l

0.66

470

2438

Alcohol use disorder, Swedish definition

643

3475

1.70

33.98

1.5

80.24

33.14

g/l

0.49

571

3156

690

3631

1.66

33.86

1.5

76.89

33.18

g/l

0.49

615

3298

1144

3854

1.51

33.78

1.5

1.4

32.14

40.82

g/l

0.57

1040

3499

Factors influencing health status and contact with health services

290

627

2.34

33.57

1.5

1.4

32.14

33.42

g/l

0.82

259

572

Other disorders of kidney and ureter

216

885

2.50

33.54

1.6

1.5

27.47

32.18

g/l

6.04

186

801

Early onset COPD

299

1407

2.16

33.34

1.4

1.5

34.84

32.96

g/l

1.80

268

1274

L02BA Anti-estrogens

182

689

2.68

33.09

1.4

35.99

32.84

g/l

3.04

172

632

L02BG Aromatase inhibitors

310

1462

2.12

33.06

1.4

35.78

32.70

g/l

4.62

290

1339

Other acute lower respiratory infections

622

3541

1.69

32.46

1.5

32.74

32.57

g/l

0.12

571

3205

Diabetes medication

1001

3844

1.53

32.07

1.5

1.4

32.05

41.32

g/l

0.63

902

3511

Other retinal disorders

821

3972

1.58

32.04

1.5

29.52

40.50

g/l

0.82

741

3604

Disorders of choroid and retina

943

4321

1.54

32.03

1.5

30.43

40.21

g/l

0.79

851

3924

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1019

4274

1.51

31.80

1.5

1.4

61.82

33.02

g/l

0.48

932

3879

Drug-induced neutropenia

121

375

3.32

31.78

1.4

1.5

36.51

32.91

g/l

2.53

112

339

Type 2 diabetes, definitions combined

903

3384

1.56

31.74

1.5

1.4

32.04

42.86

g/l

0.65

815

3105

Abnormal findings on examination of blood, without diagnosis

633

3458

1.67

31.70

1.5

31.23

41.24

g/l

0.60

565

3140

Hypokalaemia

181

700

2.64

31.66

1.5

1.4

30.39

32.75

g/l

1.57

166

642

Injuries to the head

1097

4379

1.49

31.59

1.5

1.4

59.56

33.26

g/l

0.47

995

3975

Symptoms and signs involving the urinary system

858

4174

1.56

31.55

1.5

1.4

31.68

40.32

g/l

0.64

755

3809

Glomerulonephritis

150

528

2.91

31.53

1.6

1.5

26.01

32.04

g/l

5.32

128

477

Type 2 diabetes, strict (exclude DM1)

909

3418

1.55

31.49

1.5

1.4

32.09

42.76

g/l

0.65

818

3136

Used for control exclusion in common control thyroid runs

1017

3376

1.53

31.40

1.6

1.4

31.95

42.32

g/l

0.61

918

3070

Malignant neoplasm of breast, HER-negative

161

562

2.78

31.34

1.3

1.4

32.62

28.94

g/l

3.23

148

487

Malignant neoplasm of breast, ER-negative, including Hilmo

169

588

2.72

31.28

1.3

1.4

32.24

28.99

g/l

2.69

156

510

Pneumonia due to other infectious organisms, not elsewhere classified

105

5.72

30.86

1.8

1.4

31.97

29.61

g/l

0.60

Other/unspecified cytomegaloviral diseases

7.53

30.82

1.6

1.5

27.40

32.53

g/l

1.46

Stroke, including SAH

813

3735

1.57

30.76

1.5

30.10

41.15

g/l

0.76

717

3394

Pneumonia due to Streptococcus pneumoniae

124

5.23

30.53

1.4

34.78

29.99

g/l

1.66

113

Non-small cell lung cancer, squamous, helper endpoint

130

436

3.10

30.10

1.4

1.5

36.05

29.85

g/l

7.83

123

393

Benign neoplasm of colon, rectum, anus and anal canal

797

4343

1.56

30.08

1.5

1.4

31.19

39.77

g/l

0.66

702

3956

Autoimmune diseases

1071

3655

1.49

30.00

1.5

1.4

32.00

41.54

g/l

0.61

975

3324

Diabetic retinopathy, excluding more controls

326

881

2.10

29.95

1.5

1.4

28.97

32.68

g/l

5.02

287

799

Bronchitis

1095

4472

1.47

29.84

1.5

1.4

32.30

39.77

g/l

0.57

1003

4047

Abnormalities of heart beat

345

1726

1.95

29.57

1.5

1.4

118.44

33.26

g/l

0.48

313

1562

Disorders of gallbladder, biliary tract and pancreas

1029

4325

1.49

29.45

1.5

1.4

32.00

40.07

g/l

0.60

936

3921

Other CVD

341

1769

1.96

29.21

1.6

1.5

30.17

30.93

g/l

0.54

306

1579

Amiodarone users

188

773

2.50

29.17

1.5

27.87

31.59

g/l

3.89

160

698

Gastroduodenal ulcer

409

2242

1.84

29.15

1.5

1.4

30.08

32.26

g/l

2.73

365

2031

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

240

3.84

29.00

1.7

1.5

29.88

27.41

g/l

0.91

212

Non-follicular lymphoma

173

686

2.59

28.96

1.7

1.5

31.61

31.69

g/l

0.03

165

618

Hydronephrosis

167

650

2.62

28.89

1.4

32.41

32.90

g/l

0.20

154

594

Coagulation defects, purpura and other haemorrhagic conditions

249

1166

2.17

28.18

1.5

31.08

32.38

g/l

0.87

225

1059

Misadventures to patients during surgical and medical care

200

864

2.35

27.61

1.7

1.4

30.13

32.39

g/l

1.74

186

780

Cytomegaloviral disease, including avohilmo

5.95

27.50

1.6

1.5

680.75

32.17

g/l

0.49

Type 2 diabetes, definitions combined, including avohilmo

882

3375

1.52

27.47

1.5

1.4

32.05

42.93

g/l

0.66

801

3093

All influenza (not pneumonia)

133

472

2.85

27.41

1.5

1.4

30.38

32.50

g/l

0.97

121

441

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1083

3958

1.46

27.41

1.6

1.4

32.39

33.16

g/l

1.11

968

3597

Asthma/COPD (KELA code 203)

883

3931

1.51

27.39

1.5

1.4

32.58

40.72

g/l

0.54

812

3572

Mental and behavioural disorders due to alcohol

564

3276

1.65

27.36

1.5

86.79

33.07

g/l

0.49

507

2969

Diseases of peritoneum

157

611

2.63

27.26

1.6

1.5

28.20

31.74

g/l

2.54

143

556

Senile cataract

713

2750

1.59

27.24

1.5

30.31

45.25

g/l

0.76

644

2497

Stroke, excluding SAH

778

3663

1.54

27.20

1.5

30.06

41.15

g/l

0.75

682

3327

Mental and behavioural disorders due to alcohol, excluding acute intoxication

500

2940

1.70

27.19

1.5

94.04

33.13

g/l

0.49

448

2666

Retention of urine

518

2504

1.69

26.63

1.6

1.5

31.25

44.34

g/l

0.56

445

2288

Colorectal cancer, including Hilmo

293

1381

2.00

26.58

1.4

1.5

30.96

51.63

g/l

0.44

262

1216

Cytomegalovirus infection, IBD co-morbidity

5.84

26.41

1.6

1.5

680.75

32.78

g/l

0.49

Cytomegaloviral disease

5.82

26.39

1.6

1.5

680.75

32.17

g/l

0.49

Sub-endpoint used in defining T1D endpoints

333

1740

1.90

26.36

1.5

26.75

32.30

g/l

11.72

286

1574

Pneumonia derived septicemia

179

4.18

26.35

1.4

1.5

33.67

32.00

g/l

0.45

161

Cellulitis

271

1346

2.04

26.24

1.5

31.64

32.66

g/l

0.62

245

1223

Intestinal infectious diseases, including avohilmo, including avohilmo

1138

4451

1.43

26.06

1.5

1.4

30.51

40.34

g/l

0.83

1034

4040

Squamous cell neoplasms and carcinomas of the skin

160

642

2.54

26.04

1.5

30.31

27.35

g/l

2.21

140

559

Asthma (diagnoses ohter than nonallergic)

862

4700

1.49

25.95

1.5

1.4

32.68

39.37

g/l

0.52

786

4261

Codeine or tramadol medication

1084

4101

1.44

25.84

1.5

1.4

59.92

32.94

g/l

0.49

1009

3704

Pain, not elsewhere classified

271

1352

2.02

25.83

1.5

1.4

34.77

33.93

g/l

0.46

243

1222

Convulsions, not elsewhere classified

231

1079

2.13

25.38

1.5

33.68

33.75

g/l

0.03

209

972

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

188

813

2.33

25.26

1.5

29.97

27.63

g/l

1.75

166

701

Pain in limb

816

3453

1.51

25.22

1.5

1.4

32.37

42.11

g/l

0.57

741

3120

Intestinal stricture

415

2400

1.75

24.98

1.4

1.5

31.30

32.13

g/l

0.62

373

2166

Secondary right heart disease

286

3.38

24.97

1.5

28.61

30.95

g/l

1.09

258

Need for other prophylactic measures

275

3.40

24.96

1.5

31.39

32.30

g/l

0.25

245

Ischaemic Stroke, excluding all haemorrhages

744

3611

1.53

24.91

1.5

29.51

41.21

g/l

0.79

656

3289

Purpura and other haemorrhagic conditions

186

817

2.32

24.76

1.5

30.97

32.37

g/l

0.82

174

741

Other disorders of glucose regulation and pancreatic internal secretion

119

422

2.88

24.76

1.7

1.5

28.95

31.42

g/l

1.20

103

382

Other interstitial pulmonary diseases

256

1279

2.04

24.61

1.5

32.93

31.40

g/l

1.09

222

1148

Exposure to unspecified factor

976

4613

1.44

24.61

1.5

1.4

32.07

39.76

g/l

0.62

885

4186

Alcoholic liver disease

157

643

2.50

24.56

1.8

1.5

225.85

33.13

g/l

0.48

139

580

Interstitial lung disease endpoints

256

1281

2.04

24.50

1.5

32.93

31.35

g/l

1.14

222

1151

Interstitial lung disease

256

1281

2.04

24.50

1.5

32.93

31.35

g/l

1.14

222

1151

Unspecified haematuria

571

2911

1.61

24.48

1.5

30.92

42.99

g/l

0.61

501

2653

ILD, hospital admissions

251

1249

2.05

24.41

1.5

32.87

31.35

g/l

1.06

218

1122

Unspecified acute lower respiratory infection

195

879

2.25

24.37

1.4

1.5

32.01

32.34

g/l

0.14

178

796

Idiopathic gout

176

763

2.37

24.34

1.7

1.5

29.11

32.32

g/l

3.03

157

687

Diabetic maculopathy, excluding more controls

146

581

2.56

24.21

1.6

1.4

26.43

33.25

g/l

7.55

124

539

Persons encountering health services for specific procedures, not carried out

270

3.35

24.14

1.6

1.4

34.99

33.33

g/l

0.50

243

Emphysema

135

521

2.66

23.97

1.3

1.5

32.92

31.11

g/l

0.84

122

458

Paralytic ileus and intestinal obstruction

358

2007

1.80

23.95

1.4

31.37

32.30

g/l

0.68

323

1817

Pneumococcal septicemia

179

4.01

23.87

1.4

33.62

32.16

g/l

0.36

162

Symptoms and signs involving the digestive system and abdomen

959

3314

1.46

23.78

1.5

1.4

32.44

42.32

g/l

0.56

865

3014

Oesophageal varices

221

3.66

23.73

1.8

1.6

26.97

32.22

g/l

2.64

195

Viral pneumonia (known virus, not influenza)

163

4.17

23.60

1.6

1.5

30.20

30.94

g/l

0.17

149

Other cataract

527

2419

1.63

23.51

1.5

30.52

46.48

g/l

0.69

483

2194

Presence of other functional implants

679

3037

1.54

23.43

1.5

1.4

30.29

43.89

g/l

0.77

621

2769

Other soft tissue disorders, not elsewhere classified

893

3486

1.46

23.31

1.5

1.4

32.43

42.02

g/l

0.57

809

3149

Diagnoses used for exclusion with ILD

338

1882

1.82

23.24

1.5

31.58

31.95

g/l

0.21

308

1682

Hypertrophic cardiomyopathy

251

3.43

22.89

1.7

1.5

27.39

31.77

g/l

2.11

226

Viral pneumonia (unknown virus, not influenza)

290

3.20

22.87

1.7

1.5

353.29

31.94

g/l

0.49

260

Osteoporosis

347

1794

1.80

22.72

1.5

30.19

31.93

g/l

1.69

304

1623

Fracture of femur

419

2240

1.71

22.71

1.4

1.5

29.79

31.10

g/l

1.26

377

2000

Lymphoid leukaemia

104

361

2.97

22.69

1.6

1.5

30.97

31.39

g/l

0.12

325

Osteomyelitis

111

399

2.86

22.66

1.7

1.5

28.40

31.76

g/l

1.89

365

Constipation

930

4410

1.44

22.65

1.5

1.4

32.61

39.70

g/l

0.52

844

4004

Lung diseases due to external agents

227

1120

2.06

22.61

1.5

31.82

30.74

g/l

0.63

204

998

Other diseases of intestines

936

3635

1.44

22.41

1.5

1.4

32.85

41.82

g/l

0.55

844

3314

Nausea and vomiting

307

1636

1.85

22.29

1.6

1.4

31.02

32.46

g/l

1.15

272

1471

Other pulmonary heart/vessel disease

319

3.08

22.04

1.5

28.62

31.01

g/l

1.15

290

Benign neoplasm: Colon

671

4206

1.51

22.02

1.5

31.14

39.89

g/l

0.65

589

3831

Hepatic failure, not elsewhere classified

209

3.62

21.91

1.7

1.4

25.52

32.83

g/l

4.69

190

Colorectal cancer

258

1287

1.94

21.81

1.4

1.5

30.70

53.23

g/l

0.45

230

1132

Malignant neoplasm of head and neck, including Hilmo

123

475

2.63

21.72

1.4

1.5

32.94

28.44

g/l

3.05

107

416

Alcohol use disorder, ICD-based

447

2737

1.65

21.71

1.5

101.48

33.19

g/l

0.50

400

2478

Diseases of the skin and subcutaneous tissue

915

3196

1.44

21.65

1.5

1.4

31.84

33.53

g/l

3.30

829

2896

Left bundle-branch block

279

3.17

21.63

1.4

29.45

37.42

g/l

7.65

266

Amyloidosis

140

4.28

21.35

1.8

1.4

25.18

31.01

g/l

2.73

128

Injuries to the hip and thigh

605

3564

1.53

21.34

1.5

30.95

32.33

g/l

1.90

552

3223

Amputation of foot

195

3.72

21.28

1.7

1.6

26.31

31.09

g/l

2.16

178

Open wound of head

612

3793

1.52

21.25

1.5

80.46

32.90

g/l

0.48

562

3424

Fentanyl

157

686

2.32

21.15

1.6

1.5

35.86

29.60

g/l

7.42

151

597

Pleural plaque with presence of asbestos

161

717

2.32

21.12

1.4

1.5

35.19

30.34

g/l

5.98

153

640

Disorders of thyroid, IBD co-morbidities

156

451

2.39

20.83

1.6

1.3

33.20

35.55

g/l

1.31

138

414

Secondary malignant neoplasm of other and unspecified sites

5.26

20.70

1.4

34.01

27.11

g/l

2.46

Other (not insulin) diabetes medications

919

3813

1.42

20.67

1.5

1.4

32.70

41.29

g/l

0.56

824

3482

Chronic ulcer of skin, not elsewhere classified

118

461

2.62

20.51

1.6

1.4

31.08

31.47

g/l

0.13

111

425

Polyneuropathies and other disorders of the peripheral nervous system

299

1674

1.81

20.31

1.5

29.06

32.31

g/l

4.32

277

1501

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

130

535

2.49

20.25

1.6

1.5

31.20

31.44

g/l

0.07

120

490

Gastric ulcer

262

1412

1.88

20.15

1.5

1.4

28.70

31.67

g/l

3.36

231

1264

Persons encountering health services in other circumstances

387

2304

1.67

20.08

1.5

1.4

106.19

33.39

g/l

0.48

367

2105

Acute bronchitis

465

2873

1.60

20.07

1.5

32.84

32.21

g/l

0.49

427

2589

Chronic pancreatitis

172

800

2.19

20.06

1.5

30.42

33.09

g/l

1.68

155

719

Malignant neoplasm of head and neck

107

402

2.71

20.02

1.4

1.5

32.83

28.51

g/l

2.54

351

Intracranial trauma

508

2180

1.58

19.81

1.5

1.4

91.98

34.22

g/l

0.48

459

1973

Amyloidosis, other/unspecified

118

4.48

19.79

1.7

1.4

24.53

31.34

g/l

3.26

108

Angina pectoris

588

2563

1.53

19.76

1.5

1.4

30.95

46.67

g/l

0.75

520

2360

Mycoses

307

1746

1.77

19.70

1.5

31.77

32.68

g/l

0.57

273

1579

Other or unspecified ileus, impaction or obstruction

261

1415

1.87

19.67

1.4

31.87

31.77

g/l

0.04

235

1270

Hypotension

282

1568

1.83

19.66

1.6

1.5

29.54

30.81

g/l

0.97

251

1395

Hypoglycaemia, other or unspecified

340

2.85

19.55

1.7

1.4

28.52

31.72

g/l

1.48

304

Gout due to impairment of renal function

6.08

19.33

1.4

1.3

23.73

28.60

g/l

1.19

Fracture of rib(s), sternum and thoracic spine

390

2383

1.65

19.24

1.5

32.40

32.14

g/l

0.16

361

2142

Nephrotic syndrome

142

4.01

19.19

1.5

1.4

24.80

32.33

g/l

2.75

129

Examination and observation for other reasons

562

2061

1.55

19.18

1.6

1.4

32.94

33.63

g/l

0.58

509

1881

L04AX Other immunosuppressants

502

3252

1.55

19.15

1.5

1.4

34.23

42.83

g/l

0.45

470

2966

Certain disorders involving the immune mechanism

205

1035

2.00

19.14

1.7

1.4

30.78

33.08

g/l

1.70

186

941

Substance use, excluding alcohol

170

801

2.14

19.07

1.4

1.5

214.29

34.31

g/l

0.50

154

728

Reimbursement for rheumatic diseases

532

3474

1.53

19.06

1.5

1.4

33.73

33.10

g/l

0.53

501

3149

Insulin, fast-acting (human)

136

587

2.34

18.92

1.5

1.4

26.28

32.62

g/l

6.52

116

536

Problems related to lifestyle

104

397

2.65

18.83

1.5

1.4

329.61

34.07

g/l

0.50

362

Hernia

877

4174

1.40

18.79

1.4

32.27

40.35

g/l

0.58

796

3782

Status post-ami

359

1621

1.70

18.77

1.5

28.16

52.43

g/l

0.73

311

1496

In situ neoplasms

463

2965

1.57

18.76

1.4

1.5

31.68

32.16

g/l

0.36

412

2682

Bronchiectasis

121

501

2.47

18.63

1.6

1.4

33.40

31.61

g/l

0.88

109

448

Decubitus ulcer and pressure area

115

466

2.53

18.60

1.5

29.21

31.21

g/l

0.98

426

Falls/tendency to fall

910

3263

1.40

18.53

1.5

1.4

32.06

33.85

g/l

3.78

822

2971

Injuries to the thorax

533

3527

1.52

18.51

1.5

1.4

32.42

41.05

g/l

0.50

497

3172

Second line medication for Crohn's disease

506

3309

1.54

18.47

1.5

1.4

34.23

42.67

g/l

0.45

474

3017

Sequelae of external causes of morbidity and mortality

302

1745

1.75

18.40

1.5

1.4

31.62

32.41

g/l

0.48

272

1579

Injuries to the abdomen, lower back, lumbar spine and pelvis

452

2849

1.57

18.36

1.5

31.43

32.28

g/l

0.73

415

2565

119

495

2.43

18.00

1.5

1.4

36.10

33.50

g/l

1.44

104

449

Other disorders of skin and subcutaneous tissue, not elsewhere classified

183

910

2.04

17.91

1.5

31.00

31.90

g/l

0.46

171

828

Malignant neoplasm of oral cavity, including Hilmo

183

3.47

17.74

1.3

1.5

32.37

28.71

g/l

1.08

159

Other and unspecified polyneuropathies, also in other diseases

265

1493

1.80

17.73

1.5

29.23

32.03

g/l

3.16

245

1340

ILD, hospital admissions 1, main diag only

212

1116

1.93

17.69

1.5

32.47

31.30

g/l

0.63

182

1003

Thrombocytopenia, unspecified

104

412

2.58

17.60

1.5

31.01

32.18

g/l

0.46

371

Malignant neoplasm of colon, including Hilmo

200

1027

1.96

17.59

1.3

1.5

31.78

28.66

g/l

2.96

179

897

Cardiomyopathy in other diseases

15.01

17.55

1.8

1.5

24.21

37.44

g/l

3.92

Haemorrhage, not elsewhere classified

246

3.10

17.52

1.4

29.05

32.01

g/l

1.30

222

Biguanides

904

3968

1.38

17.47

1.5

1.4

32.80

40.73

g/l

0.53

808

3617

Elevated blood glucose level

108

437

2.52

17.45

1.5

30.42

31.87

g/l

0.48

398

Left ventricular outflow tract obstruction (LVOTO), broad definition

107

433

2.51

17.26

1.5

31.29

33.63

g/l

1.00

394

Other symptoms and signs involving the circulatory and respiratory systems

269

2.95

17.19

1.5

1.4

32.51

32.98

g/l

0.11

250

Infection of intervertebral disc (pyogenic)

5.09

17.10

1.9

1.5

30.86

30.19

g/l

0.10

Abnormal findings on diagnostic imaging of other body structures

156

745

2.12

17.03

1.8

1.4

32.76

31.97

g/l

0.31

144

671

Persons with potential health hazards related to communicable diseases

231

1252

1.84

16.85

1.4

171.21

34.51

g/l

0.49

199

1141

Other disorders involving the immune mechanism, not elsewhere classified

133

3.87

16.75

1.5

28.61

32.39

g/l

1.08

118

Other arthritis (FG)

316

1897

1.68

16.74

1.5

1.4

32.48

33.70

g/l

1.02

296

1709

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

137

3.77

16.72

1.4

1.5

37.81

33.87

g/l

1.43

123

Rheumatoid arthritis

362

1984

1.63

16.68

1.5

1.4

34.06

33.17

g/l

0.65

341

1785

Immunodeficiencies

186

3.35

16.61

1.7

1.4

31.66

32.95

g/l

0.28

165

Diabetic retinopathy

436

1731

1.58

16.53

1.5

28.65

31.49

g/l

4.44

383

1549

Cutaneous abscess, furuncle and carbuncle

250

1413

1.78

16.47

1.6

1.4

148.08

33.30

g/l

0.49

235

1284

N06DA Anticholinesterases

229

3099

0.56

16.31

1.3

1.5

30.56

31.18

g/l

0.35

207

2780

Use of anticholinesterases

229

3099

0.56

16.31

1.3

1.5

30.56

31.18

g/l

0.35

207

2780

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

100

404

2.52

16.26

1.7

1.5

29.70

32.06

g/l

1.08

366

Malignant melanoma, including Hilmo

173

875

2.00

16.15

1.6

1.5

31.59

28.74

g/l

2.30

154

766

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

123

3.94

16.12

1.6

1.5

29.37

31.77

g/l

0.55

108

Unstable angina pectoris

445

2284

1.54

16.00

1.5

1.4

29.96

47.26

g/l

0.73

393

2106

Open wound of lower leg

170

858

2.00

15.99

1.6

1.5

30.68

32.11

g/l

0.84

148

782

Benzodiazepine use

934

4693

1.35

15.88

1.4

1.5

66.39

32.69

g/l

0.53

850

4258

Malignant melanoma

156

766

2.06

15.84

1.7

1.5

31.70

28.67

g/l

2.36

140

669

Aortic valve malfunction, age under 60 years

100

411

2.47

15.66

1.5

31.09

33.59

g/l

1.05

372

Fracture of lumbar spine and pelvis

298

1795

1.67

15.54

1.6

1.5

30.04

31.49

g/l

1.14

268

1611

Chronic nephritic syndrome

195

3.22

15.46

1.8

1.4

24.46

32.56

g/l

3.54

177

Seropositive rheumatoid arthritis

278

1643

1.70

15.37

1.4

34.69

32.95

g/l

1.38

261

1474

ILD medications: azathioprine

124

564

2.22

15.33

1.5

1.4

32.03

33.50

g/l

0.56

114

515

Genitourinary diseases

482

1590

1.53

15.33

1.5

1.4

31.94

35.59

g/l

7.35

432

1471

Rheumatoid arthritis, including avohilmo

384

2474

1.56

15.27

1.5

1.4

33.98

32.50

g/l

1.49

362

2232

Abnormal results of function studies

375

2.51

15.17

1.7

1.5

32.63

32.83

g/l

0.05

339

Other disorders of white blood cells

289

2.76

15.17

1.6

1.5

35.44

32.29

g/l

1.13

258

Diabetic retinopathy, strict definition

214

1048

1.84

15.15

1.6

1.5

26.22

31.86

g/l

7.94

182

935

Multiple myeloma, including Hilmo

229

3.00

15.13

1.4

1.5

29.16

27.45

g/l

0.38

200

Dermatitis

604

4168

1.42

15.13

1.5

1.4

32.60

40.26

g/l

0.53

551

3767

Unspecified privation

124

570

2.21

15.01

1.7

1.5

31.96

31.69

g/l

0.08

107

516

Symptoms and signs concerning food and fluid intake

131

614

2.16

15.00

1.4

1.5

31.25

32.58

g/l

0.50

117

552

Congenital malformations of heart and great arteries

112

479

2.29

14.86

1.6

1.5

32.18

33.04

g/l

0.29

101

430

Diverticular disease of intestine

752

3402

1.38

14.81

1.5

1.4

31.44

42.02

g/l

0.63

670

3101

Benign neoplasms

857

3445

1.36

14.80

1.5

1.4

32.47

41.92

g/l

0.55

775

3129

380

2438

1.55

14.79

1.4

33.08

32.94

g/l

0.08

348

2208

Autoimmune diseases related-to ILD

752

4608

1.37

14.56

1.5

1.4

32.33

39.64

g/l

0.58

682

4189

Complications of cardiac and vascular prosthetic devices, implants and grafts

143

3.58

14.48

1.8

1.4

26.78

31.07

g/l

1.66

130

Discitis, unspecified

4.21

14.45

1.4

33.59

29.98

g/l

0.82

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

142

675

2.06

14.41

1.6

1.5

29.85

33.52

g/l

2.67

125

611

Artificial opening status

303

2.67

14.38

1.5

1.4

31.94

33.42

g/l

0.47

277

Other gastritis (incl. Duodenitis)

263

1573

1.69

14.27

1.6

1.4

149.94

32.68

g/l

0.49

230

1417

Medical observation and evaluation for suspected diseases and conditions

592

2108

1.44

14.27

1.5

1.4

31.81

33.50

g/l

2.32

542

1924

Gastrointestinal diseases

406

1310

1.56

14.23

1.5

1.4

32.36

34.39

g/l

2.23

362

1196

Other diseases of intestine

195

1074

1.84

14.16

1.5

1.4

30.42

32.47

g/l

1.22

172

975

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

101

437

2.34

14.15

1.4

32.98

32.83

g/l

0.04

396

Disorders of mineral metabolism

104

456

2.32

14.15

1.5

1.4

31.40

33.26

g/l

0.70

421

Tobacco use

211

2.99

14.09

1.5

34.01

33.01

g/l

0.23

188

Symptoms and signs involving cognition, perception, emotional state and behaviour

882

4432

1.33

14.06

1.5

32.00

39.99

g/l

0.62

788

4039

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

121

567

2.17

14.01

1.5

32.01

32.14

g/l

0.03

107

503

Dysphagia

290

1788

1.64

13.97

1.5

1.4

31.62

32.55

g/l

0.69

272

1611

Other embolism and thrombosis

159

824

1.96

13.96

1.5

30.46

31.98

g/l

0.80

149

746

Malignant neoplasm of bladder, including Hilmo

154

779

1.98

13.94

1.4

1.5

30.79

28.42

g/l

1.58

131

684

Vascular disorders of the intestines

115

530

2.21

13.94

1.5

27.81

30.88

g/l

1.79

108

487

Other external causes of accidental injury

691

2489

1.40

13.91

1.6

1.4

31.79

33.86

g/l

3.84

625

2252

Other diseases of arteries and capillaries

113

518

2.22

13.83

1.5

1.4

28.58

32.26

g/l

2.17

103

464

Cholelithiasis, broad definition with cholecystitis

838

4177

1.34

13.77

1.4

32.19

40.21

g/l

0.57

762

3788

Azathioprine

124

591

2.12

13.68

1.5

32.03

33.47

g/l

0.55

114

537

Chronic periodontitis, complicated

561

3885

1.41

13.59

1.4

1.5

33.59

40.86

g/l

0.46

506

3543

Other and unspecified dermatitis

494

3433

1.45

13.59

1.5

1.4

31.93

42.05

g/l

0.60

447

3115

Colorectal adenocarcinoma

207

1159

1.78

13.57

1.3

1.5

30.98

55.77

g/l

0.45

186

1022

Other specified/unspecified arthritis

278

1709

1.64

13.55

1.5

1.4

32.29

33.65

g/l

1.08

259

1543

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

148

732

1.98

13.55

1.6

1.5

29.78

33.40

g/l

2.79

131

661

Accidents

688

2489

1.39

13.52

1.5

1.4

31.69

33.86

g/l

4.18

621

2252

Thyrotoxicosis, other and/or unspecified

181

989

1.85

13.46

1.5

30.85

33.16

g/l

1.66

159

900

Seropositive rheumatoid arthritis, wide

278

1714

1.64

13.42

1.4

1.5

34.69

32.30

g/l

2.32

261

1548

Sequelae with surgical and medical care as external cause

235

1388

1.71

13.42

1.6

1.4

31.70

32.32

g/l

0.31

215

1256

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

269

1647

1.65

13.36

1.4

1.5

34.68

32.19

g/l

2.38

254

1493

Sulfasalazine

245

1465

1.68

13.29

1.5

1.4

35.54

33.46

g/l

1.76

224

1333

Finngen Rheumatological endpoints

800

3382

1.35

13.26

1.5

1.4

32.52

42.45

g/l

0.57

731

3052

Malignant neoplasm of colon

161

855

1.90

13.13

1.4

1.5

31.08

28.21

g/l

2.15

145

738

Candidiasis

142

723

1.98

13.12

1.5

31.85

32.53

g/l

0.23

126

650

Dentofacial anomalies [including malocclusion]

207

2748

0.59

12.97

1.5

1.4

35.86

34.20

g/l

1.29

195

2531

Other infectious diseases, including avohilmo

118

567

2.11

12.86

1.7

1.5

291.85

31.29

g/l

0.49

105

515

Thyrotoxicosis

224

1321

1.71

12.84

1.5

30.70

33.08

g/l

2.01

198

1207

Asthma and opportunity respiratory infection

298

2.58

12.80

1.5

34.22

31.60

g/l

1.03

269

Other and unspecified disorders of white blood cells

218

2.87

12.79

1.7

1.4

33.85

31.84

g/l

0.50

197

Unspecified fall

515

3579

1.42

12.78

1.4

31.12

32.80

g/l

2.35

470

3237

Other/unspecified seropositive rheumatoid arthritis

272

1691

1.62

12.73

1.4

1.5

34.61

32.25

g/l

2.21

256

1528

Duodenal ulcer

163

880

1.88

12.73

1.5

1.4

32.23

31.51

g/l

0.28

146

793

Other complications of surgical and medical care, not elsewhere classified

102

465

2.22

12.67

1.4

34.23

32.77

g/l

0.55

430

Other and unspecified local infections of skin and subcutaneous tissue

108

504

2.17

12.66

1.6

1.5

31.91

32.79

g/l

0.32

100

455

Other viral diseases

209

1212

1.73

12.53

1.5

177.50

33.63

g/l

0.49

190

1109

Malignant neoplasm of oral cavity

141

3.34

12.51

1.4

1.5

32.43

28.10

g/l

1.11

121

Fitting and adjustment of other devices

361

2106

1.52

12.50

1.4

30.32

46.52

g/l

0.58

332

1890

Malignant neoplasm of tongue, including Hilmo

103

3.79

12.46

1.4

32.57

27.27

g/l

1.41

Malignant melanoma of skin, including Hilmo

136

696

1.97

12.41

1.6

1.5

31.13

28.61

g/l

1.70

120

608

Aortic aneurysm

320

2041

1.55

12.34

1.5

31.41

32.62

g/l

1.00

289

1862

Vitreous haemorrhage

127

637

2.02

12.33

1.4

1.5

28.26

31.83

g/l

2.50

112

574

Concussion

413

2176

1.48

12.33

1.5

1.4

105.42

34.20

g/l

0.49

378

1969

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

902

4446

1.30

12.31

1.5

1.4

31.23

40.33

g/l

0.74

824

4036

Periodontitis

899

4411

1.30

12.12

1.4

1.5

33.52

39.77

g/l

0.44

826

3994

Chronic apical periodontitis

982

4279

1.29

12.06

1.5

1.4

63.93

32.88

g/l

0.50

891

3881

IgA nephropathy (IgA glomerulonephritis)

101

3.77

12.04

1.5

28.29

32.09

g/l

0.91

Chronic periodontitis, including avohilmo

898

4415

1.30

12.03

1.4

1.5

33.57

39.76

g/l

0.43

825

3998

Use of rivastigmine

1591

0.42

12.00

1.3

1.5

30.30

30.15

g/l

0.04

1411

Respiratory conditions due to other external agents

116

3.58

11.95

1.3

1.5

33.89

31.73

g/l

0.54

106

Other special examinations and investigations of persons without complaint or reported diagnosis

580

2108

1.40

11.95

1.6

1.4

32.41

33.50

g/l

1.17

529

1924

Adenocarcinoma and ductal carcinoma of pancreas

172

3.04

11.87

1.4

1.5

35.02

27.87

g/l

1.98

149

Other and unspecified drugs and medicaments

427

2.23

11.83

1.4

1.5

32.90

32.47

g/l

0.11

383

Attention to artificial openings

205

2.84

11.82

1.2

1.4

32.57

31.34

g/l

0.28

185

Viral infections characterized by skin and mucous membrane lesions

375

2542

1.48

11.79

1.6

1.4

31.99

33.16

g/l

1.05

334

2317

Congenital malformations of the circulatory system

120

582

2.02

11.69

1.6

1.5

31.71

33.81

g/l

1.02

107

525

Obesity related asthma

309

2019

1.54

11.67

1.5

1.4

33.09

33.69

g/l

0.40

284

1840

Disorders of calcium metabolism

354

2.36

11.66

1.5

1.4

33.01

32.76

g/l

0.06

325

Malignant neoplasm of pancreas

355

2.35

11.58

1.4

1.5

34.06

27.33

g/l

3.26

311

Carcinoma in situ of skin of other and unspecified parts of face

144

775

1.89

11.47

1.5

30.39

30.53

g/l

0.05

126

702

Injury of other and unspecified intrathoracic organs

383

2.29

11.40

1.4

1.5

34.10

31.75

g/l

0.98

343

Other local infections of skin and subcutaneous tissue

112

553

2.05

11.37

1.6

1.5

32.17

32.72

g/l

0.19

104

502

Other infectious diseases

100

474

2.14

11.36

1.7

1.5

346.23

31.39

g/l

0.49

433

Other viral diseases, including avohilmo

246

1519

1.61

11.33

1.5

1.4

157.52

34.18

g/l

0.49

220

1391

Candidiasis, including avohilmo

250

1570

1.60

11.25

1.5

1.4

31.99

32.93

g/l

0.56

229

1429

Systemic connective tissue disorders

343

2311

1.49

11.23

1.5

1.4

31.16

32.55

g/l

1.24

310

2099

Other/unspecified rheumatoid arthritis

144

780

1.87

11.17

1.5

32.21

31.38

g/l

0.36

134

707

Congenital malformations of cardiac septa

198

2.77

11.17

1.8

1.4

32.12

32.49

g/l

0.07

177

Malignant melanoma of skin

113

565

2.02

11.08

1.7

1.5

31.07

28.51

g/l

1.53

100

489

Pneumonitis due to solids and liquids

124

642

1.96

11.08

1.6

1.5

29.81

30.10

g/l

0.08

111

576

Abdominal and pelvic pain

855

3314

1.30

10.89

1.5

1.4

32.29

42.32

g/l

0.57

774

3014

Other (seronegative) rheumatoid arthritis, wide

196

1169

1.69

10.89

1.4

1.5

32.35

32.01

g/l

0.15

185

1051

Poisoning by drugs, medicaments and biological substances

159

893

1.79

10.88

1.4

1.5

35.95

33.77

g/l

1.25

142

814

Covid-19 suspected case

150

828

1.82

10.88

1.7

1.5

34.25

33.53

g/l

0.29

134

749

Intracranial injury

555

3809

1.36

10.86

1.5

86.24

32.97

g/l

0.48

502

3449

Thyrotoxicosis with toxic multinodular goitre

347

2.32

10.85

1.7

1.5

32.69

32.17

g/l

0.14

317

Delirium, not induced by alcohol and other psychoactive substances

190

1127

1.70

10.75

1.4

1.5

31.09

30.54

g/l

0.22

167

1002

Seropositive rheumatoid arthritis, strict definition

150

834

1.82

10.69

1.5

36.89

32.54

g/l

3.45

139

749

Other antidepressants

946

3788

1.28

10.69

1.5

65.07

32.73

g/l

0.51

866

3446

Unspecific neurodegenerative disorder

326

3275

0.68

10.67

1.3

1.5

30.55

31.47

g/l

0.73

289

2954

Malignant neoplasm of pancreas, including Hilmo

446

2.14

10.65

1.4

1.5

34.60

27.37

g/l

4.32

387

Pulmonary oedema

126

3.30

10.55

1.5

26.50

29.37

g/l

0.78

117

Acute pancreatitis

215

1326

1.64

10.51

1.5

1.4

30.80

32.47

g/l

1.09

192

1192

Other nutritional deficiencies

512

3418

1.37

10.48

1.5

1.4

33.28

42.43

g/l

0.52

472

3116

Cholecystitis

177

1041

1.72

10.41

1.4

1.5

33.39

31.16

g/l

1.30

158

924

Acidosis

117

3.35

10.37

1.4

1.5

29.49

31.76

g/l

0.44

108

Disorders of other endocrine glands

368

2519

1.44

10.21

1.4

30.76

32.86

g/l

2.34

335

2281

Vascular diseases of the intestine

270

2.46

10.17

1.4

28.10

31.36

g/l

1.29

250

Alzheimer disease, including avohilmo

291

2989

0.67

10.15

1.4

1.5

30.76

31.18

g/l

0.25

260

2691

Cholelithiasis

780

4131

1.29

10.14

1.4

1.5

32.03

40.25

g/l

0.58

706

3745

Use of memantine

204

2610

0.62

10.04

1.4

1.5

29.65

30.81

g/l

0.74

181

2338

Use of other anti-dementia drugs

204

2610

0.62

10.04

1.4

1.5

29.65

30.81

g/l

0.74

181

2338

Chronic gastritis

309

2098

1.48

9.83

1.6

1.4

31.13

32.32

g/l

0.94

270

1895

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

3.76

9.78

1.4

1.3

32.82

26.83

g/l

1.44

Phlebitis and thrombophlebitis (not including DVT)

223

1414

1.59

9.74

1.4

1.5

34.69

32.54

g/l

1.53

204

1275

Septal defects

182

2.72

9.71

1.7

1.4

33.92

32.43

g/l

0.36

163

Other viral diseases, not elsewhere classified

141

793

1.78

9.57

1.5

34.10

32.82

g/l

0.57

129

728

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

101

512

1.98

9.56

1.3

1.5

36.60

34.52

g/l

0.79

463

Other specified/unspecified systemic involvement of connective tissue

229

2.53

9.55

1.3

1.4

31.19

33.75

g/l

0.69

206

Fracture of lower leg, including ankle

475

3431

1.36

9.50

1.5

1.4

96.41

33.47

g/l

0.49

428

3118

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

163

948

1.70

9.47

1.4

1.5

36.08

34.42

g/l

0.88

146

876

External causes of morbidity and mortality

512

1878

1.37

9.47

1.6

1.4

32.04

34.03

g/l

2.93

470

1690

Superficial injury of head

236

1524

1.56

9.47

1.5

31.03

32.14

g/l

0.71

218

1369

Arterial embolism and thrombosis

395

2.14

9.41

1.4

26.56

31.11

g/l

2.65

358

Diabetic maculopathy

145

783

1.77

9.41

1.6

1.5

26.51

31.53

g/l

4.66

123

702

Alcohol dependence

261

1729

1.52

9.38

1.6

1.5

149.97

33.24

g/l

0.51

238

1556

Pain (limb, back, neck, head abdominally)

654

2493

1.32

9.38

1.6

1.4

31.70

45.46

g/l

0.59

583

2271

Malignant neoplasm of stomach, including Hilmo

305

2.30

9.37

1.3

1.5

33.57

27.05

g/l

4.25

266

Exclusions for E4_PCOS_CONSORTIUM

446

2009

1.39

9.37

1.4

34.59

32.87

g/l

1.92

411

1828

Other diseases of pancreas

105

546

1.95

9.33

1.5

30.49

32.40

g/l

0.78

487

Tuberculosis, IBD comorbidity

100

513

1.98

9.26

1.5

34.53

30.18

g/l

2.45

466

Obesity due to excess calories

346

2427

1.43

9.25

1.5

1.4

33.56

33.89

g/l

0.19

322

2223

DVT of lower extremities

212

1348

1.59

9.21

1.4

1.5

32.88

31.79

g/l

0.53

184

1203

Congenital malformations, deformations and chromosomal abnormalities

384

2601

1.40

9.14

1.6

1.4

31.87

34.03

g/l

2.84

352

2376

Other functional intestinal disorders

445

2961

1.37

9.11

1.5

1.4

32.19

43.18

g/l

0.55

399

2697

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

274

1846

1.49

9.07

1.5

30.85

33.42

g/l

2.76

247

1698

Other neurological diseases

734

4462

1.28

9.06

1.5

30.72

39.64

g/l

0.72

665

4039

Thoracic aortic aneurysm

175

1069

1.66

9.00

1.4

1.5

32.66

33.18

g/l

0.23

162

969

Open wound of ankle and foot

504

1.96

8.97

1.5

31.49

32.93

g/l

0.48

456

Alcohol withdrawal state with delirium

403

2.09

8.96

1.5

398.57

32.32

g/l

0.50

362

Pyogenic arthritis

437

2.04

8.93

1.4

1.5

29.65

32.33

g/l

1.22

396

Other noninfective gastroenteritis and colitis

223

1445

1.55

8.86

1.4

1.5

31.46

32.29

g/l

0.44

198

1301

Asthma, including avohilmo

1019

4551

1.24

8.83

1.5

1.4

32.73

39.69

g/l

0.53

939

4119

Corns and callosities

359

2.15

8.81

1.5

33.29

32.09

g/l

0.33

322

Drug-induced hypoglycaemia without coma

3.57

8.74

1.7

1.5

28.62

30.34

g/l

0.28

Injury, poisoning and certain other consequences of external causes

421

1517

1.40

8.74

1.6

1.4

32.21

34.06

g/l

2.18

386

1370

Dizziness and giddiness

692

4216

1.28

8.61

1.5

32.11

40.13

g/l

0.58

622

3839

Asthma, hospital admissions , main diagnosis only

683

4654

1.28

8.61

1.5

1.4

32.56

39.54

g/l

0.55

622

4221

Poisoning by medicine

135

779

1.74

8.54

1.3

1.5

35.57

33.86

g/l

0.81

120

710

Supplementary factors related to causes of morbidity and mortality classified elsewhere

273

1862

1.47

8.54

1.5

31.39

32.92

g/l

1.09

249

1688

General examination and investigation of persons without complaint and reported diagnosis

537

2096

1.33

8.48

1.5

1.4

86.64

33.51

g/l

0.48

506

1913

Benign neoplasm: Colon, unspecified

294

2040

1.45

8.46

1.5

29.96

32.34

g/l

2.53

244

1842

Tubulo-interstitial nephritis, not specified as acute or chronic

340

2.14

8.36

1.5

29.74

31.99

g/l

0.88

312

Sequelae of cerebrovascular disease

454

2890

1.35

8.34

1.4

1.5

30.31

42.76

g/l

0.63

410

2627

Amputation of ankle bones

162

2.74

8.34

1.4

1.6

24.55

30.78

g/l

2.28

149

Malignant neoplasm of stomach

276

2.28

8.33

1.4

1.5

33.39

27.11

g/l

3.55

243

Colon adenocarcinoma

119

669

1.80

8.29

1.3

1.5

31.29

27.98

g/l

2.06

108

579

Dementia in Alzheimer disease

122

1745

0.58

8.25

1.3

1.5

29.56

30.20

g/l

0.25

105

1570

Noninfectious colitis NAS

125

715

1.76

8.21

1.4

1.5

31.12

32.31

g/l

0.45

110

651

Acute pancreatitis (for exclusion)

215

1413

1.53

8.12

1.5

30.80

32.12

g/l

0.78

192

1281

Migraine, single triptan purchase ok & required. ICD-code if available is included

247

2452

0.68

8.09

1.4

34.84

34.47

g/l

0.18

219

2259

Triptan medication for migraine, single purchase ok

247

2452

0.68

8.09

1.4

34.84

34.47

g/l

0.18

219

2259

Other viral diseases, not elsewhere classified, including avohilmo

174

1084

1.60

8.03

1.5

1.4

33.62

33.63

g/l

0.00

156

992

Disorder of lipoprotein metabolism, unspecified

152

924

1.66

8.02

1.5

1.4

31.20

32.51

g/l

0.60

136

834

Other spirochaetal diseases

123

2082

0.59

8.01

1.4

1.5

33.44

33.63

g/l

0.06

112

1902

Zoster [herpes zoster]

204

1332

1.54

7.95

1.6

1.5

31.76

31.74

g/l

0.01

182

1195

Intestinal malabsorption

201

2.47

7.93

1.8

1.4

26.12

33.30

g/l

3.01

179

Other spirochaetal diseases, including avohilmo

125

2101

0.59

7.92

1.4

1.5

33.32

33.61

g/l

0.10

113

1919

Acute posthaemorrhagic anaemia

214

2.43

7.89

1.2

1.5

30.18

31.37

g/l

0.24

196

Spondyloarthritis

165

1027

1.62

7.89

1.5

32.80

32.25

g/l

0.22

150

927

Spirochaetal infections, other/unspecified, including avohilmo

124

2084

0.59

7.86

1.4

1.5

33.32

33.61

g/l

0.10

113

1904

Sulfonylureas

446

2657

1.34

7.83

1.6

1.5

29.17

43.16

g/l

0.66

386

2412

Tuberculosis, wide

100

544

1.86

7.83

1.5

34.53

30.01

g/l

2.62

493

Statin medication

462

1941

1.34

7.82

1.5

1.4

31.17

50.49

g/l

0.68

409

1787

malignant neoplasm of male genital organs

276

1139

1.47

7.82

1.5

31.63

57.58

g/l

0.47

236

1009

ILD-related respiratory insufficiency

253

2.31

7.81

1.4

1.5

31.73

31.33

g/l

0.08

229

Lyme disease, including avohilmo

123

2067

0.59

7.80

1.4

1.5

33.44

33.62

g/l

0.06

112

1889

Lyme disease

123

2067

0.59

7.80

1.4

1.5

33.44

33.62

g/l

0.06

112

1889

Fracture of shoulder and upper arm

344

2486

1.39

7.79

1.4

1.5

31.14

32.65

g/l

1.40

313

2253

Diseases of the myoneural junction and muscle

140

840

1.68

7.79

1.4

1.5

30.75

31.57

g/l

0.31

128

752

Degeneration of macula and posterior pole

583

3500

1.29

7.78

1.4

1.5

30.05

41.03

g/l

0.69

538

3170

Multiple myeloma and malignant plasma cell neoplasms

345

2.10

7.74

1.5

29.77

30.98

g/l

0.27

312

Chronic diseases of tonsils and adenoids

323

2829

0.72

7.73

1.4

34.16

34.06

g/l

0.05

298

2596

Tuberculosis, wide, including avohilmo

100

547

1.85

7.70

1.5

34.53

30.04

g/l

2.60

496

Use of donepezil

137

2127

0.61

7.69

1.3

1.5

30.55

30.47

g/l

0.02

123

1895

Persons encountering health services for examination and investigation

549

2108

1.31

7.64

1.6

1.4

32.10

33.50

g/l

1.73

495

1924

Weight loss

114

650

1.77

7.63

1.4

1.5

31.93

31.91

g/l

0.00

100

587

Right hemicolectomy

408

1.99

7.63

1.3

1.5

29.46

31.32

g/l

0.58

372

Malignant neoplasm of rectum

505

1.88

7.62

1.5

30.28

28.37

g/l

0.73

439

Caries of enamel

468

4013

0.76

7.61

1.5

1.4

34.73

41.10

g/l

0.40

429

3662

malignant neoplasm of male genital organs, including Hilmo

277

1148

1.46

7.59

1.5

32.08

57.42

g/l

0.46

237

1018

Alzheimer disease

268

2724

0.70

7.57

1.4

1.5

30.33

30.96

g/l

0.39

237

2448

Type of accident

253

1744

1.46

7.56

1.5

31.06

32.72

g/l

1.19

231

1580

Other diseases of urinary system

873

3985

1.23

7.52

1.5

1.4

31.79

40.74

g/l

0.63

770

3642

Malignant neoplasm of rectum, including Hilmo

110

623

1.78

7.52

1.4

1.5

30.89

28.42

g/l

1.17

547

Urinary track infection

321

1135

1.42

7.46

1.4

32.17

34.90

g/l

2.62

294

1051

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

425

2909

1.33

7.43

1.6

1.4

32.08

34.05

g/l

2.67

390

2658

Other disorders of veins

349

2512

1.37

7.40

1.5

1.4

33.34

33.29

g/l

0.03

315

2279

Embolic stroke with flimmer

137

2.76

7.39

1.4

25.39

33.18

g/l

3.24

126

Malignant neoplasm of corpus uteri, including Hilmo

310

2.12

7.39

1.3

1.4

34.27

27.94

g/l

3.57

268

Malignant neoplasm of tongue

3.46

7.30

1.5

1.4

34.53

27.30

g/l

1.70

Thiazolidinediones

136

827

1.66

7.24

1.7

1.5

31.96

32.00

g/l

0.01

119

753

Obesity

458

3292

1.31

7.21

1.5

1.4

33.53

33.73

g/l

0.13

423

3004

Mantle cell lymphoma, including Hilmo

3.54

7.20

1.6

1.4

34.98

26.57

g/l

3.00

Any mental disorder

932

3832

1.22

7.20

1.4

1.5

33.02

33.12

g/l

0.08

842

3489

Benign thyroid growths and nodules

289

1917

1.41

7.08

1.5

1.4

32.90

32.51

g/l

0.21

265

1742

Personality disorders, excluding more controls

133

807

1.65

7.00

1.4

263.12

35.26

g/l

0.50

121

743

Obesity and other hyperalimentation

459

3311

1.31

6.98

1.5

1.4

33.50

33.73

g/l

0.15

424

3022

Soft tissue disorders

842

3518

1.23

6.96

1.5

1.4

31.22

41.94

g/l

0.67

763

3179

Tuberculosis

472

1.87

6.93

1.5

35.44

29.96

g/l

3.31

428

Other reaction to severe stress, and adjustment disorders

201

1346

1.50

6.93

1.4

34.98

34.49

g/l

0.22

182

1236

Carcinoma in situ of skin of scalp and neck

254

2.23

6.93

1.5

31.36

30.06

g/l

0.28

231

Familial hypercholesterolemia

171

1110

1.55

6.93

1.7

1.5

31.07

32.41

g/l

0.72

161

999

Other specified disorders of kidney and ureter

160

2.55

6.89

1.3

1.5

28.75

32.07

g/l

0.74

146

Sequelae of other external causes

286

2.12

6.88

1.5

29.30

32.31

g/l

1.12

255

Mental and behavioural disorders due to sedatives or hypnotics

215

2.30

6.86

1.3

1.4

659.32

33.58

g/l

0.49

192

Other and unspecified coagulation defects

172

2.47

6.86

1.5

1.4

31.92

32.41

g/l

0.08

156

Suicide or other Intentional self-harm

159

1017

1.57

6.83

1.4

1.5

35.99

33.94

g/l

1.18

142

928

Transient ischemic attack

569

3579

1.27

6.82

1.5

30.11

41.31

g/l

0.73

513

3257

Other and unspecified nonorganic psychotic disorders

111

649

1.72

6.80

1.5

304.62

34.49

g/l

0.50

102

593

Abnormal findings in nipple discharge synovial fluid wound secretions

3.98

6.76

1.4

1.5

30.51

33.38

g/l

0.47

Multiple myeloma

144

2.62

6.75

1.4

1.5

28.22

27.22

g/l

0.15

125

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

144

2.62

6.75

1.4

1.5

28.22

27.22

g/l

0.15

125

Other symptoms and signs involving the digestive system and abdomen

139

865

1.62

6.73

1.5

1.4

34.04

32.87

g/l

0.46

131

794

Congenital malformations of the urinary system

230

2.24

6.71

1.7

1.4

26.14

32.54

g/l

3.17

204

Noninfective enteritis and colitis

369

2765

1.34

6.69

1.4

1.5

31.26

33.30

g/l

2.27

333

2498

Actinic keratosis

479

3387

1.29

6.68

1.5

31.44

40.61

g/l

0.51

428

3052

Smoking dependency

413

1.91

6.68

1.4

1.6

36.36

33.06

g/l

1.51

373

Other coagulation defects

330

2.02

6.67

1.5

31.10

32.70

g/l

0.42

296

Mental and behavioural disorders due to tobacco

414

1.90

6.63

1.4

1.5

36.36

33.08

g/l

1.49

375

Respiratory tuberculosis, confirmed and not-confirmed

401

1.93

6.62

1.5

36.63

30.68

g/l

3.25

363

Respiratory tuberculosis

401

1.93

6.62

1.5

36.63

30.68

g/l

3.25

363

Retinal vascular disorders

152

972

1.58

6.62

1.5

29.52

31.18

g/l

0.96

134

868

Malignant neoplasm of prostate

269

1123

1.43

6.61

1.5

31.54

57.80

g/l

0.47

229

996

Injuries to the elbow and forearm

556

3771

1.27

6.59

1.4

31.89

33.29

g/l

1.69

501

3425

Left ventricular outflow tract obstruction, narrow definition

182

2.39

6.55

1.4

1.5

30.22

32.73

g/l

0.58

163

Alzheimer’s disease, strict definition

203

2375

0.68

6.55

1.4

1.5

30.45

30.67

g/l

0.10

179

2138

500

3529

1.28

6.47

1.5

31.58

40.35

g/l

0.51

443

3182

Adenocarcinoma and papilloma adenocarcinoma of rectum

497

1.81

6.45

1.4

1.5

30.56

28.50

g/l

0.78

433

Cyst of kidney

462

1.84

6.43

1.5

29.96

32.40

g/l

1.07

415

Complications of internal orthopaedic prosthetic devices, implants and grafts

239

1686

1.43

6.41

1.5

1.4

30.91

32.40

g/l

1.17

209

1533

Degenerative diseases of the nervous system

306

2975

0.74

6.41

1.4

1.5

30.78

31.21

g/l

0.26

272

2669

Other disorders of urethra and urinary system

633

3539

1.25

6.40

1.4

31.72

41.41

g/l

0.60

557

3240

Neurological diseases, wide definition

155

488

1.60

6.40

1.5

1.3

32.41

36.04

g/l

2.41

140

447

Malignant neoplasm of bladder

441

1.86

6.38

1.5

30.58

26.94

g/l

2.05

387

Retinal vascular occlusion

149

958

1.57

6.36

1.5

29.79

31.18

g/l

0.75

132

855

Acquired haemolytic anaemia

137

2.61

6.34

1.6

1.5

26.18

31.60

g/l

1.58

122

Alcohol abuse, main dg, excluding more controls

120

732

1.65

6.32

1.4

1.5

288.07

33.55

g/l

0.50

108

673

Alzheimer’s disease (Late onset)

191

2287

0.68

6.32

1.4

1.5

30.11

30.52

g/l

0.21

168

2058

Malignant neoplasm of corpus uteri

289

2.06

6.31

1.3

1.4

33.79

27.38

g/l

3.33

248

Skin changes due to chronic exposure to nonionizing radiation

483

3429

1.28

6.30

1.5

31.43

40.54

g/l

0.51

430

3090

Malignant neoplasm of prostate, including Hilmo

270

1135

1.41

6.30

1.5

31.94

57.58

g/l

0.46

230

1007

L01XX Other antineoplastic agents

394

1.91

6.30

1.3

1.5

32.59

32.09

g/l

0.14

357

Symptoms and signs involving the skin and subcutaneous tissue

607

4615

1.24

6.28

1.5

81.84

32.99

g/l

0.49

555

4182

Methotrexate

114

688

1.67

6.27

1.5

1.4

33.39

32.72

g/l

0.22

106

625

Injuries to unspecified part of trunk, limb or body region

561

1.74

6.25

1.6

1.5

31.83

32.19

g/l

0.11

504

Use of disulfiram, acamprosate or naltrexone

345

1.96

6.25

1.7

1.5

34.87

34.37

g/l

0.12

311

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

13.56

6.21

1.4

1.5

36.28

26.26

g/l

—

Psychiatric diseases

840

3475

1.21

6.19

1.5

32.96

33.17

g/l

0.18

756

3162

Injuries to the knee and lower leg

992

4505

1.19

6.16

1.5

1.4

62.78

33.18

g/l

0.48

894

4096

Diseases of pulp and periapical tissues, including avohilmo

899

3869

1.20

6.16

1.5

1.4

32.78

32.69

g/l

0.07

812

3497

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

163

1075

1.52

6.14

1.4

1.5

36.08

34.09

g/l

1.16

146

983

Diseases of the eye and adnexa

533

2100

1.27

6.14

1.5

1.4

33.06

49.25

g/l

0.59

488

1916

Other symptoms and signs involving the urinary system

115

701

1.66

6.13

1.7

1.5

30.42

31.57

g/l

0.50

100

638

Paracetamol or NSAID medication

138

430

1.63

6.10

1.5

30.89

30.47

g/l

0.15

122

386

Chronic myeloid leukaemia, including Hilmo

5.36

6.09

1.8

1.3

34.19

24.97

g/l

2.37

Unknown and unspecified causes of morbidity

328

1.97

6.07

1.5

32.22

32.26

g/l

0.01

303

Abdominal aortic aneurysm (AAA)

145

930

1.56

6.05

1.6

1.4

29.46

31.48

g/l

1.16

130

832

Other skin changes

207

1439

1.45

6.05

1.5

31.25

31.91

g/l

0.35

190

1293

Other and unspecified myopathies

102

605

1.70

6.04

1.5

29.60

31.45

g/l

0.75

542

Osteonecrosis

350

1.94

6.03

1.4

1.5

33.56

32.44

g/l

0.33

321

Assault

420

1.84

6.03

1.4

1.5

35.31

34.44

g/l

0.21

381

Other diseases of stomach and duodenum

408

1.86

5.97

1.7

1.5

29.66

32.10

g/l

0.89

377

Diaphragmatic hernia

354

2690

1.32

5.97

1.5

32.14

43.89

g/l

0.53

321

2434

Benign neoplasm: Transverse colon

125

785

1.61

5.93

1.4

1.5

33.53

32.25

g/l

0.59

112

709

Myeloproliferative diseases

534

1.74

5.91

1.3

1.5

32.47

31.78

g/l

0.24

482

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

526

1.74

5.90

1.4

1.5

30.36

28.72

g/l

0.58

458

Abnormal weight loss

101

602

1.69

5.88

1.4

1.5

32.42

32.07

g/l

0.08

540

Osteoporosis with pathological fracture (FG)

508

1.75

5.77

1.4

28.67

31.72

g/l

1.28

455

Other symptoms and signs involving cognitive functions and awareness

502

3544

1.26

5.77

1.4

1.5

31.08

41.14

g/l

0.62

444

3232

Diabetic neuropathy

142

921

1.55

5.75

1.6

1.5

27.90

31.22

g/l

2.21

124

813

Postmenopausal atrophic vaginitis

843

0.59

5.74

1.4

1.3

33.64

32.51

g/l

0.39

755

Dementia, including avohilmo

392

3437

0.77

5.71

1.3

1.5

30.79

40.63

g/l

0.57

352

3097

Low back pain

642

3535

1.23

5.68

1.4

31.51

41.70

g/l

0.63

582

3189

Other necrotizing vasculopathies

459

1.79

5.67

1.6

1.5

30.24

31.62

g/l

0.48

420

Disorders of parathyroid gland

206

1432

1.43

5.66

1.5

29.89

31.72

g/l

1.17

183

1286

Cystic kidney disease

139

2.49

5.65

1.7

1.5

24.19

32.36

g/l

3.42

125

Gastro-oesophageal reflux disease

569

3887

1.24

5.57

1.5

1.4

33.56

33.33

g/l

0.17

517

3549

Other metabolic disorders

520

1.72

5.57

1.6

1.4

30.61

34.05

g/l

1.52

480

Congenital malformations of the urinary system, including avohilmo

256

2.05

5.55

1.8

1.5

26.18

32.20

g/l

3.03

229

Cerebral palsy and other paralytic syndromes

597

1.67

5.53

1.6

1.5

32.31

31.57

g/l

0.21

539

Diseases of the musculoskeletal system and connective tissue

389

1496

1.31

5.51

1.6

1.4

32.23

54.43

g/l

0.56

348

1344

Abscess of anal and rectal regions

361

1.87

5.50

1.4

1.5

32.70

33.49

g/l

0.19

331

Dementia

367

3236

0.77

5.50

1.3

1.5

30.25

41.17

g/l

0.61

330

2916

Other systemic involvement of connective tissue (FG)

232

1645

1.39

5.47

1.4

31.56

32.79

g/l

0.76

210

1480

Disorders of the thyroid gland

800

4341

1.20

5.44

1.5

1.4

32.57

39.76

g/l

0.52

735

3932

Haemolytic anaemias

193

2.21

5.38

1.5

1.4

28.30

31.31

g/l

0.73

174

Schizophrenia or delusion, excluding more controls

197

1371

1.42

5.35

1.4

189.30

33.72

g/l

0.50

178

1254

Familial hypercholesterolemia, with ischemic heart disease

115

729

1.59

5.31

1.8

1.4

30.91

32.68

g/l

0.83

108

669

Intestinal adhesions without obstruction

545

1.69

5.25

1.4

29.44

31.43

g/l

0.85

499

Emotionally unstable personality disorder

241

2.04

5.23

1.6

1.5

41.01

35.40

g/l

2.70

222

Other and unspecified vascular occlusions

114

724

1.59

5.22

1.5

30.89

31.13

g/l

0.07

101

646

Malignant neoplasm of cervix uteri, including Hilmo

3.68

5.22

1.5

1.1

29.24

26.29

g/l

0.30

Alcohol-induced chronic pancreatitis

355

1.85

5.17

1.6

1.5

34.71

32.54

g/l

0.57

321

Fall involving bed

244

2.05

5.14

1.3

1.5

29.25

29.52

g/l

0.05

223

Injury of intra-abdominal organs

2.88

5.11

1.4

1.6

36.30

32.66

g/l

0.67

Fracture of foot, except ankle

169

1170

1.45

5.10

1.4

33.40

33.74

g/l

0.13

149

1068

Injury of unspecified body region

422

1.77

5.10

1.6

1.5

32.00

31.84

g/l

0.04

381

Congenital malformations of the respiratory system, including avohilmo

3.13

5.09

1.6

1.5

33.33

33.15

g/l

0.02

Inflammatory diseases of the central nervous system

393

1.80

5.08

1.3

1.5

29.74

31.91

g/l

0.62

354

Epilepsy

278

2090

1.33

5.01

1.4

1.5

32.86

32.72

g/l

0.07

261

1894

Any prescribed medicine buy

+∞

4.98

2.2

0.0

28.28

—

g/l

—

Disease of hard tissues of teeth, NOS

339

2289

0.77

4.95

1.6

1.5

33.03

32.62

g/l

0.25

311

2065

Benign neoplasm: Ascending colon

156

1074

1.46

4.91

1.7

1.5

31.00

31.95

g/l

0.50

141

966

Fracture of forearm

422

3020

1.26

4.90

1.4

31.42

33.14

g/l

1.87

378

2752

Neuroendocrine tumor and carcinoma of lung

5.00

4.87

1.4

1.2

36.60

25.66

g/l

2.13

Mycoses, including avohilmo

732

4689

1.19

4.83

1.5

1.4

33.07

39.54

g/l

0.50

661

4258

Specific personality disorders

119

777

1.54

4.81

1.5

1.4

291.15

34.51

g/l

0.50

108

710

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

719

4706

1.19

4.80

1.5

1.4

32.42

39.60

g/l

0.58

643

4279

Mantle cell lymphoma

3.52

4.80

1.8

1.3

35.41

24.54

g/l

2.94

Abnormalities of gait and mobility

137

927

1.49

4.73

1.4

1.5

31.78

31.64

g/l

0.04

119

843

Zoster [herpes zoster], including avohilmo

475

3722

1.23

4.72

1.6

1.4

32.29

40.83

g/l

0.53

428

3379

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

132

874

1.50

4.72

1.5

1.4

37.78

33.70

g/l

3.40

123

797

Insomnia

456

3915

0.81

4.71

1.5

1.4

33.25

33.41

g/l

0.10

419

3564

Idiopathic pulmonary fibrosis

105

673

1.58

4.69

1.6

1.5

33.70

30.71

g/l

1.73

602

Other disorders of adrenal gland

191

2.12

4.69

1.6

1.5

26.89

32.61

g/l

2.01

173

Gonarthrosis, primary, with knee surgery

421

4068

0.80

4.68

1.5

1.4

32.54

39.85

g/l

0.48

391

3661

Spondylopathies

708

3515

1.19

4.65

1.5

1.4

32.66

41.57

g/l

0.52

650

3170

Alcohol abuse, main dg

120

792

1.52

4.65

1.4

1.5

288.07

33.58

g/l

0.50

108

720

Dermatophytosis

134

906

1.49

4.64

1.5

31.59

32.68

g/l

0.44

120

821

Acute epiglottitis

3.40

4.63

2.0

1.6

31.28

33.99

g/l

0.43

Leisure time condition

152

1054

1.45

4.61

1.4

1.5

30.96

32.11

g/l

0.49

139

957

Other diseases of liver

144

990

1.46

4.57

1.7

1.5

31.08

33.28

g/l

1.12

134

902

Congenital malformations of the respiratory system

3.11

4.54

1.7

1.5

33.23

32.87

g/l

0.04

Hernia of abdominal wall

412

3315

1.25

4.52

1.4

1.5

32.71

42.13

g/l

0.52

375

3004

Fracture of neck

401

1.74

4.52

1.5

31.55

31.32

g/l

0.05

360

Carbimazole or st.post thyroidectomy, condition for graves disease

142

976

1.46

4.51

1.5

32.10

32.88

g/l

0.30

129

889

Barrett oesophagus

306

1.85

4.50

1.5

1.4

29.81

32.56

g/l

0.86

280

Cystic kidney disease, including avohilmo

162

2.19

4.46

1.7

1.5

24.32

32.32

g/l

3.56

146

Allergic bronchopulmonary aspergillosis (ABPA)

7.88

4.42

1.8

1.4

31.17

37.09

g/l

—

Carcinoma in situ of skin

100

644

1.57

4.39

1.4

1.5

32.04

31.02

g/l

0.32

581

Caries of dentine, including avohilmo

735

3179

1.18

4.35

1.5

1.4

30.94

32.66

g/l

2.94

651

2879

Diseases of pulp and periapical tissues and dental caries

639

2740

1.20

4.34

1.5

30.76

32.48

g/l

2.69

568

2470

Other and unspecified vasculitis limited to skin

132

2.32

4.33

1.6

1.5

34.00

31.77

g/l

0.32

120

Dental operations

622

2671

1.20

4.30

1.5

1.4

31.02

32.71

g/l

2.59

553

2395

Amputation of thigh

247

1.94

4.29

1.7

1.5

26.53

29.69

g/l

0.87

228

Myocardial infarction, with ST-elevation

210

1561

1.35

4.29

1.5

28.79

31.54

g/l

2.30

186

1393

Acute upper respiratory infections of multiple and unspecified sites

584

3554

1.20

4.28

1.5

1.4

32.31

33.25

g/l

0.96

532

3228

Hyperparathyroidism

177

1266

1.39

4.27

1.4

1.5

29.70

31.69

g/l

1.24

155

1130

Other diseases of biliary tract

570

1.59

4.24

1.5

1.4

30.31

31.44

g/l

0.34

516

Benign neoplasm: Sigmoid colon

196

1448

1.36

4.17

1.6

1.5

33.81

31.85

g/l

1.53

180

1304

Sequelae of injuries, of poisoning and of other consequences of external causes

175

1269

1.38

4.16

1.5

32.14

33.35

g/l

0.60

161

1154

Benign neoplasm: Rectum

189

1392

1.37

4.11

1.6

1.5

32.18

31.94

g/l

0.09

165

1256

Primary gonarthrosis, bilateral

372

3854

0.81

4.10

1.5

1.4

33.70

40.28

g/l

0.39

351

3471

Other and unspecified injuries of head

405

1.69

4.09

1.4

1.5

29.69

31.78

g/l

0.69

368

Other diseases of oesophagus

100

655

1.54

4.08

1.8

1.4

32.05

31.68

g/l

0.11

592

Temporomandibular joint disorders, including avohilmo

125

1741

0.69

4.06

1.6

1.4

34.05

34.36

g/l

0.11

118

1594

Procreative management

167

990

1.39

4.03

1.4

35.64

34.75

g/l

0.38

150

909

Focal epilepsy

179

1311

1.37

4.01

1.4

1.5

33.95

31.96

g/l

1.35

170

1187

Other systemic involvement of connective tissue

237

1812

1.31

3.99

1.4

1.5

31.44

32.32

g/l

0.50

215

1648

Postmenopausal osteoporosis with pathological fracture

386

1.70

3.98

1.2

1.4

29.13

30.88

g/l

0.46

354

Personality disorders

133

927

1.44

3.97

1.4

263.12

34.91

g/l

0.50

121

847

Sleep disorders

491

4064

0.83

3.96

1.5

1.4

33.24

33.34

g/l

0.06

450

3701

Acute alcohol intoxication, ICD10

155

1112

1.40

3.95

1.4

1.5

228.91

33.53

g/l

0.49

140

1009

Disorders of eyelid, lacrimal system and orbit

744

4679

1.17

3.94

1.4

1.5

32.22

39.37

g/l

0.57

677

4247

Exposure to other specified factors

592

4288

1.19

3.94

1.5

1.4

33.19

40.36

g/l

0.51

546

3889

Schizophrenia, schizotypal and delusional disorders

199

1487

1.34

3.93

1.4

187.59

33.55

g/l

0.50

180

1355

Exposure to other and unspecified inanimate mechanical forces

305

1.78

3.92

1.6

1.5

31.20

32.48

g/l

0.31

272

Migraine

160

1711

0.73

3.92

1.5

1.4

35.78

34.40

g/l

0.82

146

1577

Dental pulpitis, including avohilmo

439

3413

0.82

3.90

1.4

35.52

42.71

g/l

0.38

406

3118

Superficial injury of hip and thigh

148

1056

1.41

3.90

1.6

1.5

31.89

31.20

g/l

0.30

137

940

Umbilical hernia

232

1775

1.31

3.90

1.4

1.5

32.57

50.42

g/l

0.53

207

1607

Benign neoplasm: Rectum, anus and anal canal

209

1577

1.33

3.89

1.5

32.62

32.03

g/l

0.29

184

1423

Ulcer of oesophagus

482

1.61

3.86

1.6

1.4

28.94

31.98

g/l

1.41

434

Open wound of forearm

521

1.58

3.84

1.5

33.38

31.92

g/l

0.48

471

Malignant neoplasm of floor of mouth, including Hilmo

3.81

3.84

1.1

1.3

27.96

24.33

g/l

0.37

Other specified and unspecified personality disorders

285

1.80

3.84

1.4

1.5

644.22

33.62

g/l

0.49

260

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

9.33

3.84

2.4

1.8

36.57

29.24

g/l

—

Vasculitis limited to skin, not elsewhere classified

146

2.16

3.83

1.6

1.5

34.06

31.98

g/l

0.31

133

Obesity, other/unspecified

204

1536

1.33

3.83

1.6

1.4

34.43

33.69

g/l

0.38

184

1399

Schizophrenia or delusion

197

1476

1.34

3.83

1.4

189.30

33.56

g/l

0.50

178

1344

Polycythaemia vera

146

2.15

3.82

1.1

1.5

32.67

26.71

g/l

1.83

128

Sarcoidosis

106

714

1.49

3.81

1.7

1.5

31.43

33.08

g/l

0.71

644

Disorders of adult personality and behaviour

136

961

1.42

3.79

1.4

258.25

35.00

g/l

0.50

124

877

Malignant neoplasm of bone and articular cartilage

3.92

3.73

1.2

31.19

25.37

g/l

0.70

Adrenocortical insufficiency

161

2.07

3.73

1.7

1.5

25.13

33.18

g/l

2.89

145

Oesophageal obstruction

238

1.88

3.72

1.6

1.4

33.47

32.07

g/l

0.34

217

Malignant neoplasm of vulva, including Hilmo

3.90

3.71

1.5

1.2

34.29

25.08

g/l

2.21

Dental caries, including avohilmo

699

3063

1.17

3.68

1.5

1.4

30.69

32.69

g/l

3.63

615

2773

378

2650

1.23

3.68

1.4

1.5

30.06

31.61

g/l

1.73

352

2377

Injuries to the shoulder and upper arm

720

4789

1.16

3.66

1.5

1.4

32.23

39.36

g/l

0.58

661

4331

Viral and other specified intestinal infections

107

710

1.47

3.65

1.4

1.5

30.61

33.73

g/l

1.64

647

Inguinal hernia

543

3039

1.19

3.63

1.5

32.41

42.86

g/l

0.53

497

2741

Acute lymphadenitis

183

1.98

3.63

1.4

35.88

32.57

g/l

0.68

162

Benign neoplasm of other and ill-defined parts of digestive system

165

1217

1.36

3.61

1.5

30.69

32.19

g/l

0.78

140

1095

Colectomy operation

168

1243

1.36

3.60

1.3

1.5

30.88

31.72

g/l

0.38

151

1122

Fracture of skull and facial bones

164

1208

1.36

3.60

1.4

34.21

33.32

g/l

0.37

148

1101

Other nonthrombocytopenic purpura

3.13

3.57

1.8

1.4

32.39

33.74

g/l

0.14

Sleep apnoea

778

4255

1.15

3.54

1.5

1.4

34.01

40.09

g/l

0.41

713

3870

Myocardial infarction, unclassifiable

280

1986

1.27

3.53

1.4

1.5

27.31

31.04

g/l

4.84

247

1779

Respiratory disorders in diseases classified elsewhere

2.76

3.52

1.6

42.08

31.97

g/l

2.19

Infections with a predominantly sexual mode of transmission

129

914

1.41

3.52

1.4

263.18

34.79

g/l

0.49

119

832

Panic disorder

377

1.65

3.49

1.5

1.4

35.33

34.23

g/l

0.24

345

Myeloid leukaemia

166

2.02

3.47

1.6

1.5

35.43

31.37

g/l

1.63

151

Exclusions for E4_PCOS_BROAD

114

796

1.44

3.42

1.4

1.5

29.89

33.36

g/l

1.94

107

722

Liposarcoma, including Hilmo

3.84

3.42

1.0

1.5

28.75

24.74

g/l

0.35

Embolic stroke

388

1.64

3.41

1.4

1.5

29.52

30.15

g/l

0.13

356

Background retinopathy and retinal vascular changes

120

2.20

3.41

1.2

1.5

30.73

30.43

g/l

0.04

107

Triptan medication for migraine, min. 3 purchases

146

1485

0.73

3.41

1.4

36.09

34.89

g/l

0.64

134

1368

Injury of nerves and spinal cord at thorax level

7.21

3.39

2.1

1.8

32.49

31.02

g/l

—

Other and unspecified effects of external causes

163

1213

1.35

3.37

1.5

1.4

33.19

33.43

g/l

0.08

147

1098

Missing teeth due to accident, extraction or parodontitis

563

4293

1.17

3.36

1.4

1.5

32.84

39.93

g/l

0.50

512

3895

Acute alcohol intoxication

216

1675

1.29

3.35

1.4

1.5

174.65

33.06

g/l

0.50

194

1509

Melanocytic naevi of trunk

588

1.50

3.34

1.5

33.90

32.85

g/l

0.30

531

Disorders of continuity of bone

421

1.60

3.34

1.6

1.5

31.84

33.81

g/l

0.56

380

Other condition

104

719

1.45

3.33

1.5

31.68

32.97

g/l

0.47

657

Bacterial, viral and other infectious agents, including avohilmo

360

1.65

3.31

1.7

1.5

31.02

33.15

g/l

0.74

328

Hypothyroidism, strict autoimmune

557

3112

1.18

3.30

1.5

1.4

32.64

42.77

g/l

0.53

511

2833

Type 1 diabetes, strict (exclude DM2)

182

1.92

3.30

1.3

1.4

32.59

35.30

g/l

0.52

168

Other inflammatory liver diseases

323

1.68

3.28

1.8

1.4

30.47

32.76

g/l

0.57

291

Dermatitis and eczema

903

4711

1.14

3.27

1.5

1.4

32.43

39.51

g/l

0.56

836

4256

Other orthopaedic follow-up care

205

1.87

3.26

1.2

1.4

32.92

32.37

g/l

0.10

185

Palmar fascial fibromatosis [Dupuytren]

177

1343

1.33

3.25

1.5

1.4

31.58

32.25

g/l

0.31

162

1204

Disorders of sclera, cornea, iris and ciliary body

415

3469

1.20

3.25

1.4

1.5

32.54

33.24

g/l

0.51

370

3164

Cardiac murmurs and other cardiac sounds

290

1.71

3.23

1.4

35.30

32.72

g/l

0.69

268

Collagenous colitis

497

1.54

3.21

1.5

32.69

32.46

g/l

0.06

452

Other otitis externa (chronic)

325

1.67

3.21

1.5

33.03

32.45

g/l

0.12

294

Other necrotizing vasculopathies (FG)

387

1.62

3.21

1.6

1.5

30.74

31.86

g/l

0.32

351

Type 1 diabetes, definitions combined

184

1.90

3.20

1.3

1.4

32.59

35.29

g/l

0.51

169

Other diseases of anus and rectum

280

2245

1.25

3.20

1.4

30.82

32.52

g/l

1.41

251

2037

Myeloproliferative diseases (CML excluded)

491

1.54

3.17

1.2

1.5

32.04

31.84

g/l

0.05

446

Cholecystectomy

603

4419

1.16

3.14

1.4

1.5

32.26

39.49

g/l

0.54

543

4015

Other aneurysm

366

1.63

3.14

1.4

1.5

31.36

32.28

g/l

0.19

332

Coeliac disease

564

1.50

3.14

1.4

1.5

29.73

33.36

g/l

1.54

511

Disorders of skin appendages

315

2559

1.23

3.13

1.5

1.4

32.45

33.78

g/l

1.05

289

2339

Other and unspecified diseases of blood and blood-forming organs

145

2.03

3.12

1.4

1.5

30.72

31.96

g/l

0.21

130

Diseases of oral cavity, salivary glands and jaws

573

2526

1.17

3.12

1.5

30.53

32.42

g/l

2.91

498

2282

Schizophrenia

663

1.45

3.11

1.3

1.5

36.60

34.20

g/l

1.34

599

Other and unspecified injuries of lower leg

290

1.70

3.10

1.5

31.18

32.33

g/l

0.29

266

Tonsillectomy and adenotomy

142

1329

0.74

3.09

1.4

1.5

35.29

35.35

g/l

0.02

135

1210

Spinal stenosis

517

3253

1.17

3.07

1.5

1.4

31.85

41.94

g/l

0.55

470

2929

Parkinson's disease, strict definition

1280

0.69

3.04

1.6

1.5

34.80

31.09

g/l

2.27

1149

Herpesviral [herpes simplex] infections

560

1.49

3.04

1.6

1.5

32.73

32.65

g/l

0.02

514

Nontoxic multinodular goitre

156

1175

1.33

3.03

1.4

1.5

33.09

32.31

g/l

0.33

146

1072

Parkinson's disease

1359

0.70

3.01

1.5

34.96

31.25

g/l

2.54

1217

Behavioural syndromes associated with physiological disturbances and physical factors

532

4186

0.86

3.01

1.5

1.4

33.29

40.47

g/l

0.49

488

3808

Nerve, nerve root and plexus disorders

879

4677

1.13

2.98

1.5

1.4

32.11

39.52

g/l

0.60

808

4234

Symptoms and signs involving the nervous and musculoskeletal systems

481

4105

1.17

2.98

1.5

1.4

32.49

40.22

g/l

0.53

431

3733

Cholangitis (primary sclerosing, PSC)

387

1.59

2.97

1.5

30.92

31.55

g/l

0.15

345

Any dementia, excluding more controls

325

2701

0.82

2.97

1.3

1.5

30.08

31.66

g/l

1.60

291

2443

Focal epilepsy, strict definition

164

1248

1.32

2.97

1.4

1.5

33.63

31.94

g/l

1.00

156

1130

Bacterial, viral and other infectious agents

340

1.63

2.97

1.7

1.5

30.43

33.31

g/l

1.10

309

Conductive and sensorineural hearing loss

721

4194

1.14

2.96

1.4

1.5

32.03

40.09

g/l

0.57

658

3792

Oral lichen planus, including avohilmo , including avohilmo

323

0.40

2.94

2.3

1.5

33.36

32.99

g/l

0.03

293

Benign neoplasm: Adrenal gland

460

1.53

2.93

1.8

1.6

32.85

32.62

g/l

0.05

416

Dorsalgia

772

3595

1.14

2.92

1.5

1.4

32.69

41.55

g/l

0.53

700

3247

Retinal detachments and breaks

340

2823

1.21

2.92

1.4

1.5

32.71

43.55

g/l

0.51

305

2565

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

401

3255

1.19

2.92

1.5

1.4

34.10

42.68

g/l

0.45

363

2972

Postprocedural endocrine and metabolic disorders, not elsewhere classified

476

1.52

2.92

1.6

1.4

31.96

33.92

g/l

0.60

439

Secondary systemic amyloidosis

5.66

2.91

1.4

1.9

22.86

28.03

g/l

—

Fibroblastic disorders

229

1825

1.26

2.91

1.6

1.4

31.84

49.63

g/l

0.54

209

1645

Other disorders of ear

767

4367

1.14

2.89

1.4

1.5

32.27

39.98

g/l

0.57

699

3953

Fall on and from stairs and steps

209

1650

1.27

2.87

1.5

33.03

32.35

g/l

0.33

187

1496

Overexertion and strenuous or repetitive movements

446

1.53

2.87

1.6

1.5

31.49

32.88

g/l

0.41

400

Benign neoplasm of other and unspecified intrathoracic organs

2.82

2.84

1.9

1.6

36.33

32.52

g/l

0.63

Oesophagitis

314

1.64

2.83

1.7

1.4

31.47

32.06

g/l

0.11

286

Complications of labour and delivery

187

1332

0.78

2.82

1.3

1.4

36.16

34.38

g/l

1.12

175

1227

Isolated proteinuria

137

1.99

2.82

1.4

1.5

30.91

32.02

g/l

0.16

123

Alzheimer’s disease (Late onset), excluding more controls

120

1057

0.73

2.81

1.3

1.5

30.40

32.35

g/l

1.24

107

945

Any dementia

370

3039

0.84

2.78

1.4

1.5

30.02

31.42

g/l

1.48

334

2735

Parkinson's disease, including avohilmo

102

1407

0.72

2.77

1.5

34.58

31.38

g/l

2.07

1258

Coxarthrosis [arthrosis of hip](FG)

518

3070

1.16

2.76

1.5

1.4

31.56

42.95

g/l

0.60

480

2764

Other inflammation of eyelid

113

824

1.38

2.75

1.3

1.5

31.11

32.31

g/l

0.43

744

Lower back pain or/and sciatica

855

4730

1.12

2.73

1.4

1.5

32.20

39.46

g/l

0.59

776

4291

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

118

867

1.37

2.73

1.4

1.5

32.07

32.72

g/l

0.23

104

783

Seronegative rheumatoid arthritis

682

1.42

2.73

1.4

32.31

32.84

g/l

0.17

611

Varicose veins

540

3531

1.16

2.72

1.5

1.4

32.60

32.59

g/l

0.00

494

3207

Lichen simplex chronicus and prurigo

341

1.60

2.71

1.5

30.72

32.55

g/l

0.43

304

Acute and transient psychotic disorders

452

1.51

2.71

1.5

36.66

33.43

g/l

1.72

408

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

3.51

2.71

1.2

29.42

24.75

g/l

—

Melanoma in situ

303

1.63

2.69

1.6

1.5

32.18

32.20

g/l

0.01

272

Acute sinusitis

319

2411

1.20

2.68

1.5

1.4

33.25

33.98

g/l

0.46

288

2199

Other maternal disorders predominantly related to pregnancy

147

1204

0.76

2.67

1.4

35.48

35.09

g/l

0.13

134

1119

Focal epilepsy, mode (most common among epilepsy diagnosis)

151

1156

1.31

2.66

1.4

1.5

34.05

32.02

g/l

1.18

144

1047

Lesion of lateral popliteal nerve

258

1.68

2.65

1.8

1.5

34.56

32.03

g/l

0.40

231

Use of galantamine

744

0.63

2.64

1.3

1.5

32.21

29.62

g/l

0.93

668

Contact with and exposure to communicable diseases

112

817

1.37

2.64

1.4

34.40

35.34

g/l

0.32

750

Liposarcoma

3.42

2.63

1.0

1.5

27.29

24.25

g/l

—

Mental disorders, not otherwise specified

228

1.72

2.62

1.5

36.33

33.69

g/l

0.64

205

Malignant neoplasm of parotid gland

3.41

2.62

1.3

1.4

33.86

23.50

g/l

—

Spontaneous abortion

123

1101

0.75

2.62

1.3

1.4

34.91

34.11

g/l

0.29

115

1023

Follow-up examination after treatment for conditions other than malignant neoplasms

320

1771

1.21

2.61

1.5

1.4

33.05

33.50

g/l

0.25

289

1620

Visual impairment including blindness (binocular or monocular)

449

1.50

2.60

1.4

1.5

29.86

30.92

g/l

0.30

414

Alcohol-induced acute pancreatitis

192

1.79

2.60

1.5

32.96

31.87

g/l

0.17

173

Gingivitis and periodontal diseases

845

3890

1.12

2.59

1.5

32.77

40.44

g/l

0.49

758

3522

Chronic iridocyclitis

207

1.75

2.58

1.2

1.5

32.29

32.46

g/l

0.03

185

Malignant neoplasm of cervix uteri

3.63

2.58

1.4

1.1

29.14

29.54

g/l

—

Female genital prolapse

120

894

0.74

2.56

1.3

1.4

32.70

32.38

g/l

0.10

109

798

Use of antiglaucoma preparations and miotics

599

1.43

2.56

1.4

1.5

29.19

30.65

g/l

0.42

545

Abrasion of teeth

155

1988

0.78

2.53

1.4

32.59

33.97

g/l

0.76

148

1817

Other and unspecified tonsillitis

137

864

1.32

2.52

1.5

1.4

36.15

35.77

g/l

0.12

128

788

Other diseases of blood and blood-forming organs

380

1.54

2.51

1.3

1.5

31.07

31.96

g/l

0.22

342

Normal-pressure hydrocephalus

393

0.50

2.49

1.3

1.5

33.47

30.76

g/l

0.37

359

Juvenile osteochondrosis

2.33

2.49

1.1

1.5

33.61

32.73

g/l

0.11

Delivery, wide proxy

132

922

0.76

2.48

1.4

31.79

32.43

g/l

0.21

120

847

Hydrocele

136

1041

1.31

2.45

1.3

1.5

32.32

31.92

g/l

0.13

115

932

Benign neoplasm: Caecum

107

792

1.36

2.43

1.6

1.5

29.95

32.00

g/l

1.01

100

714

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

3.41

2.41

1.2

33.72

24.32

g/l

—

Leiomyosarcoma, including Hilmo

3.39

2.41

1.2

1.1

28.74

26.35

g/l

—

Viral and other specified intestinal infections, including avohilmo

136

1003

1.31

2.40

1.4

1.5

31.02

33.68

g/l

1.58

119

915

Atopic dermatitis

223

2174

0.82

2.39

1.6

1.4

33.02

34.48

g/l

0.92

208

1983

Use of selegiline

320

0.46

2.38

1.7

1.5

34.74

31.63

g/l

0.46

288

Benign paroxysmal vertigo

165

2082

0.79

2.38

1.5

34.03

32.38

g/l

0.99

145

1882

Gonarthrosis,primary

673

4562

0.89

2.36

1.5

1.4

33.08

39.21

g/l

0.45

635

4113

Tinnitus

115

1517

0.76

2.36

1.5

33.65

33.43

g/l

0.07

102

1368

Carcinoma in situ of skin of upper limb, including shoulder

214

1.71

2.35

1.3

1.5

30.14

30.54

g/l

0.06

194

Psoriasis vulgaris

140

1083

1.30

2.34

1.6

1.5

33.33

33.16

g/l

0.05

125

981

Unspecified mental disorder

240

1974

1.22

2.34

1.4

35.44

33.43

g/l

1.93

219

1801

Monoplegia

2.34

2.33

1.8

1.6

30.33

30.54

g/l

0.02

Adverse effects, not elsewhere classified

109

814

1.34

2.33

1.5

33.67

33.15

g/l

0.16

738

Other anxiety disorders

227

1577

1.23

2.32

1.5

1.4

166.79

34.43

g/l

0.49

206

1450

Other blood glucose lowering drugs, excl. Insulins

151

1183

1.28

2.30

1.5

30.57

31.94

g/l

0.68

136

1069

Traumatic subdural haemorrhage

161

1188

1.27

2.30

1.6

1.4

30.88

32.17

g/l

0.62

141

1058

Bullous disorders

365

1.52

2.28

1.6

1.5

29.12

31.40

g/l

0.72

329

Pregnancy, childbirth and the puerperium

124

848

0.76

2.28

1.5

1.4

31.86

31.57

g/l

0.08

111

770

Other dorsopathies, not elsewhere classified

774

3597

1.12

2.28

1.5

1.4

32.57

41.54

g/l

0.54

705

3249

Other disorders of amino-acid metabolism

4.00

2.27

1.4

1.6

32.97

31.44

g/l

—

Malignant neoplasm of anus and anal canal

3.99

2.27

1.7

1.2

31.40

25.22

g/l

—

Sensorineural hearing loss

696

4137

1.12

2.27

1.4

1.5

32.05

40.12

g/l

0.56

633

3739

Ingrowing nail

193

1.72

2.26

1.8

1.5

27.98

32.74

g/l

1.48

174

Benign neoplasm: Small intestine

264

1.61

2.22

1.4

1.5

28.77

31.99

g/l

0.90

241

Other and unspecified glaucoma

516

1.42

2.21

1.6

31.43

31.05

g/l

0.09

475

Other and unspecified pemphigoid

2.56

2.21

1.9

1.5

29.29

30.70

g/l

0.15

Peptic ulcer

2.55

2.20

1.8

1.4

31.06

30.94

g/l

0.01

260

2026

1.20

2.20

1.4

1.5

29.58

31.22

g/l

1.42

244

1811

Nonorganic sleeping disorders, excluding more controls

110

831

1.33

2.19

1.5

1.4

32.83

33.41

g/l

0.18

100

761

Drug-induced adrenocortical insufficiency

2.27

2.19

1.7

1.5

22.74

32.74

g/l

1.71

Injury of muscle and tendon at shoulder and upper arm level

221

2674

0.82

2.18

1.6

1.5

32.56

44.50

g/l

0.53

210

2421

Alzheimer’s disease (Atypical or mixed)

1162

0.73

2.18

1.3

1.5

29.87

29.57

g/l

0.08

1032

Non-selective monoamine reuptake inhibitors

297

2410

1.18

2.17

1.4

1.5

33.22

32.58

g/l

0.41

266

2184

Kela-code for severe mental illness

220

1811

1.22

2.16

1.4

1.5

35.35

33.29

g/l

1.88

201

1655

Noninflammatory disorders of female genital tract

145

928

0.78

2.16

1.4

1.3

34.01

32.62

g/l

0.57

134

831

Nonalcoholic fatty liver disease

427

1.46

2.15

1.9

1.5

33.10

33.96

g/l

0.18

383

Rheumatic valve diseases

152

1.80

2.14

1.5

1.4

28.89

30.20

g/l

0.33

135

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

132

1028

1.29

2.12

1.4

1.5

32.67

32.76

g/l

0.03

118

933

Abnormal serum enzyme levels

317

2612

1.17

2.09

1.5

30.96

44.02

g/l

0.58

278

2365

Other specified and unspecified disorders of iris and ciliary body

5.12

2.08

2.0

1.6

33.02

26.12

g/l

—

Combinations of oral blood glucose lowering drugs

250

2094

1.20

2.08

1.4

1.5

31.95

47.44

g/l

0.55

221

1906

Degenerative macular diseases

117

902

1.30

2.06

1.5

29.76

31.30

g/l

0.81

108

803

Scabies, including avohilmo

473

1.42

2.05

1.2

1.5

31.47

33.97

g/l

0.83

432

Abnormal findings on examination of urine, without diagnosis

247

1.59

2.02

1.4

1.5

28.98

31.99

g/l

0.72

219

Malignant neoplasm of parotid gland, including Hilmo

2.67

2.02

1.3

1.4

33.86

24.40

g/l

—

Iridocyclitis

164

1321

1.25

2.02

1.4

1.5

33.85

32.74

g/l

0.49

147

1199

Heartburn

577

1.37

2.00

1.5

1.4

33.49

32.73

g/l

0.20

531

Urticaria and erythema

217

1800

1.21

2.00

1.5

33.17

33.52

g/l

0.14

198

1647

Dysplasia of cervi uteri

592

0.70

1.99

1.2

1.4

36.30

33.54

g/l

0.85

546

Eating disorder

111

1.89

1.99

1.1

1.4

34.11

35.90

g/l

0.24

105

Migraine without aura and triptan purchases

338

0.53

1.98

1.6

1.4

37.49

35.29

g/l

0.51

313

Neurological diseases

610

2729

1.12

1.98

1.5

1.4

32.17

44.73

g/l

0.59

551

2465

Ventral hernia

202

1667

1.22

1.98

1.4

1.5

32.55

32.82

g/l

0.11

189

1499

Benign neoplasm of other and unspecified endocrine glands

751

1.32

1.97

1.7

1.5

33.01

32.56

g/l

0.13

683

Other peripheral vascular diseases

386

1.46

1.97

1.4

32.74

32.75

g/l

0.00

355

Hydrocephalus

548

0.63

1.96

1.4

1.5

34.23

31.75

g/l

0.55

496

Malignant neoplasm of oropharynx

2.21

1.95

1.2

1.4

36.47

27.69

g/l

1.97

Carcinoma in situ of other and unspecified genital organs

2.21

1.95

2.1

1.2

31.44

34.64

g/l

0.45

Macular pucker

160

1292

1.24

1.95

1.5

30.21

32.45

g/l

1.40

142

1156

Benign neoplasm of ovary

102

778

1.32

1.95

1.3

1.4

33.04

33.32

g/l

0.07

710

Complications of other internal prosthetic devices, implants and grafts

234

1.59

1.94

1.2

1.5

30.20

31.26

g/l

0.21

214

Other/unspecified dorsalgia

285

2400

1.17

1.93

1.5

1.4

32.18

32.94

g/l

0.47

255

2166

Coxarthrosis

471

2678

1.14

1.93

1.5

1.4

31.54

44.40

g/l

0.59

439

2413

Viral warts

396

1.44

1.92

1.5

29.60

32.32

g/l

0.97

360

Isolated patent ductus arteriosus

4.53

1.92

1.2

1.1

32.76

36.60

g/l

—

Diseases of salivary glands

224

1873

1.20

1.92

1.4

33.32

33.34

g/l

0.01

205

1708

Irregular menses

122

1166

0.78

1.92

1.6

1.4

35.63

34.54

g/l

0.45

116

1080

Other disorders of the musculoskeletal system and connective tissue

117

912

1.29

1.91

1.3

1.5

31.72

32.22

g/l

0.17

110

825

Sequelae of injuries of lower limb

405

1.44

1.91

1.4

1.5

32.23

32.89

g/l

0.13

365

Shoulder lesions

625

3356

1.12

1.90

1.4

33.01

42.26

g/l

0.51

575

3032

Pain in thoracic spine

100

764

1.31

1.90

1.5

1.4

34.31

33.16

g/l

0.47

699

Conjunctivitis (acute, non atopic), including avohilmo

651

4362

0.90

1.89

1.4

1.5

33.62

40.01

g/l

0.45

591

3957

Psoriasis

206

1712

1.21

1.89

1.5

33.39

33.06

g/l

0.13

186

1556

Parkinson's disease, strict definition, excluding more controls

1094

0.76

1.89

1.6

1.5

34.80

32.64

g/l

0.99

981

severe traumatic brain injury, does not include concussion

228

1914

1.20

1.88

1.5

30.51

31.50

g/l

0.56

202

1709

Keratitis

252

2134

1.18

1.88

1.4

1.5

31.72

33.27

g/l

1.11

226

1945

Speech therapy

208

1733

1.20

1.87

1.7

1.4

31.49

32.41

g/l

0.52

190

1564

Alzheimer’s disease (Atypical or mixed), excluding more controls

782

0.74

1.86

1.3

1.5

30.34

31.62

g/l

0.46

697

Necrotizing fasciitis

3.60

1.85

3.0

1.6

25.42

32.46

g/l

—

Anxiety (asthma-related co-morbidities)

313

2047

1.16

1.84

1.4

131.70

34.36

g/l

0.50

282

1889

Benign neoplasm: Parotid gland

459

1.40

1.84

1.6

1.5

32.40

32.20

g/l

0.04

412

Other specified/unspecified bacterial intestinal infections

359

1.46

1.84

1.7

1.4

30.17

32.63

g/l

0.69

320

Benign neoplasm of urinary organs

286

1.51

1.82

1.5

33.52

32.16

g/l

0.30

256

Benign neoplasm: salivary glands, exclude unknown (D119)

512

1.37

1.80

1.6

1.5

31.24

32.22

g/l

0.25

460

Pediculosis, acariasis and other infestations, including avohilmo

641

1.33

1.78

1.2

1.5

32.01

33.96

g/l

0.69

585

Benign neoplasm: Stomach

617

1.34

1.76

1.5

29.35

31.83

g/l

0.85

562

Hypothyroidism, other/unspecified

677

4028

1.11

1.76

1.5

1.4

32.49

40.25

g/l

0.52

620

3651

Bronchitis, not specified as acute or chronic

438

1.40

1.75

1.5

33.86

31.44

g/l

0.81

392

Rheumatic fever incl heart disease

209

1.59

1.75

1.5

30.28

30.59

g/l

0.06

192

Benign neoplasm: Rectosigmoid junction

265

1.52

1.74

1.4

1.5

33.30

31.66

g/l

0.29

241

Hypertrophic disorders of skin

193

1.61

1.74

1.4

1.5

28.98

32.74

g/l

1.00

175

Ulcerative enterocolitis

110

1.83

1.73

1.2

1.4

33.80

33.14

g/l

0.06

Fitting and adjustment of external prosthetic device

3.96

1.73

2.0

1.5

15.20

34.76

g/l

—

Mental retardation, wide definition

109

1.83

1.73

1.4

40.00

33.04

g/l

2.33

Arthropathies

641

2923

1.11

1.71

1.5

1.4

32.04

43.92

g/l

0.60

582

2641

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

269

2428

0.86

1.70

1.5

1.4

33.09

33.42

g/l

0.17

254

2222

Rash and other nonspecific skin eruption

517

1.36

1.70

1.6

1.5

31.44

32.23

g/l

0.21

471

Papulosquamous disorders

289

2499

1.16

1.70

1.5

33.17

33.34

g/l

0.08

259

2283

Polycystic ovarian syndrome, broad definition

118

1.78

1.69

1.2

1.5

36.62

35.70

g/l

0.09

113

Myalgia

152

1243

1.23

1.68

1.5

1.4

34.23

34.26

g/l

0.01

138

1132

Intercostal neuropathy

2.55

1.68

1.2

1.6

33.00

33.43

g/l

—

Allergic purpura

104

1.84

1.68

1.4

33.23

32.39

g/l

0.08

Malignant neoplasm of penis, including Hilmo

2.63

1.67

1.3

1.2

32.41

25.96

g/l

—

Benign neoplasm of major salivary glands

598

1.33

1.65

1.6

1.5

31.64

32.17

g/l

0.13

541

Benign neoplasm: Appendix

2.28

1.65

1.2

1.5

31.75

31.71

g/l

0.00

Cysts of oral region, not elsewhere classified

285

1.48

1.64

1.3

1.5

32.11

32.41

g/l

0.04

253

Carcinoma in situ, bladder

302

1.47

1.64

1.5

1.6

32.71

31.41

g/l

0.28

272

Visual disturbances and blindness

412

3654

1.13

1.64

1.4

1.5

31.64

32.82

g/l

1.20

374

3321

Parkinson's disease, excluding more controls

1127

0.78

1.64

1.5

34.96

32.73

g/l

1.14

1011

Presence of other devices

234

1966

1.17

1.63

1.4

1.5

28.86

33.09

g/l

6.33

218

1771

Anterior Iridocyclitis

141

1149

1.23

1.63

1.4

1.5

33.47

32.68

g/l

0.29

127

1049

Polymyalgia rheumatica

132

1069

1.24

1.62

1.3

1.5

31.07

31.08

g/l

0.00

122

963

Superficial injuries involving multiple body regions

1.85

1.62

1.4

1.5

29.91

33.01

g/l

0.59

Injuries to the ankle and foot

442

3363

1.12

1.62

1.5

1.4

33.01

33.89

g/l

0.73

394

3075

Alzheimer disease, excluding more controls

148

1165

0.82

1.59

1.4

31.33

32.72

g/l

0.75

130

1043

Acute suppurative otitis media

673

1.29

1.59

1.5

35.41

34.52

g/l

0.25

614

Schizoaffective disorder

238

1.52

1.59

1.3

1.5

35.34

33.89

g/l

0.32

214

Nontoxic goitre/thyroid nodule

211

1791

1.18

1.59

1.4

32.84

32.37

g/l

0.22

193

1628

Disorders of lacrimal system

329

2839

1.14

1.59

1.4

1.5

31.40

33.05

g/l

1.55

300

2575

Localized swelling, mass and lump of skin and subcutaneous tissue

240

2060

1.17

1.58

1.4

1.5

155.92

33.00

g/l

0.49

220

1876

Carcinoma in situ of other and unspecified sites

330

1.44

1.57

1.6

32.86

31.40

g/l

0.34

297

Retinal detachment with retinal break

115

921

1.25

1.57

1.3

1.5

32.85

32.12

g/l

0.25

107

833

Endometriosis

126

906

0.81

1.57

1.4

1.3

33.85

32.62

g/l

0.49

116

813

Diseases of inner ear

367

3960

0.88

1.56

1.4

1.5

32.98

40.28

g/l

0.47

333

3596

Otitis externa

155

1282

1.21

1.56

1.4

1.5

33.20

32.85

g/l

0.12

139

1160

Malignant neoplasm of oropharynx, including Hilmo

1.90

1.56

1.4

35.81

28.64

g/l

1.57

Female infertility, associated with anovulation

1.85

1.55

1.2

1.3

35.59

36.22

g/l

0.05

Open wound of hip and thigh

122

1.73

1.55

1.6

1.5

36.10

31.94

g/l

0.80

111

Pemphigoid

209

1.55

1.52

1.7

1.5

26.70

30.63

g/l

0.99

186

Progressive vascular leukoencephalopathy

341

1.42

1.52

1.3

1.4

30.58

30.85

g/l

0.05

315

Bipolar affective disorders

659

1.29

1.51

1.3

1.4

417.37

33.82

g/l

0.50

596

Superficial injury of abdomen, lower back and pelvis

105

838

1.26

1.49

1.5

31.97

32.64

g/l

0.21

761

Erythema multiforme

1.82

1.48

1.8

1.5

30.09

33.16

g/l

0.41

L02BB Anti-androgens

959

0.77

1.47

1.5

29.96

31.08

g/l

0.39

853

Gluteal tendinitis

203

0.49

1.47

1.1

1.5

34.08

33.08

g/l

—

188

Other strabismus

115

925

1.24

1.47

1.5

34.32

33.16

g/l

0.43

103

843

Infections with a predominantly sexual mode of transmission, including avohilmo

146

1104

1.21

1.47

1.4

234.41

35.36

g/l

0.49

136

1008

Pedal cyclist injured in transport accident

1128

0.79

1.47

1.5

34.37

33.45

g/l

0.26

1021

Burns and corrosions

636

1.29

1.47

1.4

1.5

30.60

33.24

g/l

1.01

577

Mental retardation

1.85

1.46

1.4

40.50

32.31

g/l

2.45

Herpesviral [herpes simplex] infections, including avohilmo

134

1101

1.22

1.46

1.5

33.58

33.32

g/l

0.08

118

999

Autoimmune hepatitis, wide definition

187

1.56

1.46

1.9

1.3

28.80

34.35

g/l

1.04

168

Idiopathic thrombocytopenic purpura

156

1.62

1.44

1.3

1.5

30.00

31.20

g/l

0.25

142

Injuries involving multiple body regions

164

1.59

1.43

1.4

31.74

31.97

g/l

0.04

146

Injuries to the wrist and hand

645

4666

0.91

1.43

1.5

1.4

78.41

33.21

g/l

0.49

603

4218

Acute gastritis

447

1.35

1.43

1.8

1.4

30.20

31.65

g/l

0.42

409

Faecal incontinence

525

1.32

1.43

1.4

32.96

31.75

g/l

0.32

483

Headache

362

2484

1.13

1.42

1.4

32.91

46.20

g/l

0.56

333

2261

Superficial injury of ankle and foot

430

1.35

1.42

1.6

1.5

33.20

33.58

g/l

0.08

393

Excessive, frequent and irregular menstruation

144

928

0.83

1.42

1.6

1.3

33.70

32.62

g/l

0.46

139

831

Hyperkinetic disorders (excl. ADHD)

3.09

1.42

1.4

1.5

44.52

38.83

g/l

—

Sleep apnoea, including avohilmo

771

4295

1.09

1.41

1.5

1.4

33.87

40.00

g/l

0.42

704

3907

Hallux valgus (acquired)

187

1571

0.85

1.41

1.4

32.51

33.15

g/l

0.29

175

1425

Soft tissue disorders related to use, overuse and pressure

214

1841

1.16

1.41

1.6

1.4

31.72

33.85

g/l

1.71

195

1670

Episodal and paroxysmal disorders

824

3859

1.08

1.40

1.5

1.4

32.60

40.86

g/l

0.53

734

3497

Mental retardation, excluding more controls

1.82

1.40

1.4

1.5

40.50

31.30

g/l

2.89

Disorders of male genital organs in diseases classified elsewhere

2.45

1.40

1.6

1.8

21.41

30.83

g/l

—

Pilonidal cyst

246

1.47

1.39

1.5

1.4

33.70

33.99

g/l

0.06

221

Fracture at wrist and hand level

225

1938

1.16

1.39

1.5

1.4

31.69

33.60

g/l

1.52

210

1761

Eating disorders

213

1.50

1.39

1.2

1.5

35.27

34.47

g/l

0.15

197

Other and unspecified injuries of abdomen, lower back and pelvis

2.09

1.39

1.7

1.6

28.80

33.49

g/l

0.66

Conjunctivitis (acute, non atopic)

170

1430

1.19

1.39

1.4

32.62

33.53

g/l

0.41

153

1301

Inguinal hernia, bilateral

109

883

1.24

1.39

1.6

1.5

33.62

32.09

g/l

0.64

784

Fenamates

711

0.78

1.39

1.5

31.94

30.59

g/l

0.45

633

Abnormality of red blood cells

2.66

1.37

1.7

31.25

33.71

g/l

—

Malignant neoplasm of nasal cavity and sinuses

2.65

1.37

1.0

1.3

36.57

25.41

g/l

—

Vitamin B12 deficiency anaemia

733

1.26

1.36

1.6

1.5

30.17

30.89

g/l

0.20

662

Inguinal or femoral hernia, bilateral

110

896

1.23

1.34

1.6

1.5

33.53

32.12

g/l

0.58

797

Malignant neoplasm of testis

2.15

1.34

1.7

1.5

32.18

28.22

g/l

—

Endometriosis of rectovaginal septum and vagina

346

0.63

1.34

1.2

1.3

34.09

32.67

g/l

0.18

317

Diseases of external ear

273

2401

1.14

1.33

1.4

1.5

32.38

32.82

g/l

0.22

245

2173

Acute and subacute iridocyclitis

129

1068

1.21

1.33

1.4

1.5

33.24

32.82

g/l

0.13

117

974

Dorsopathies

770

3600

1.08

1.33

1.5

1.4

32.59

41.55

g/l

0.54

703

3252

Iron deficiency

2.05

1.33

1.0

1.5

28.49

34.67

g/l

0.65

Erythema intertrigo

144

1.61

1.33

1.3

1.4

32.83

32.28

g/l

0.07

127

Other infective otitis externa

291

1.42

1.32

1.4

1.5

31.84

31.96

g/l

0.02

262

Maternal care related to the fetus and amniotic cavity and possible delivery problems

668

0.80

1.31

1.4

38.48

35.79

g/l

1.34

619

Injury of urinary and pelvic organs

1.75

1.31

1.2

1.6

29.46

32.40

g/l

0.45

Nonorganic sleeping disorders

110

898

1.23

1.31

1.5

32.82

33.29

g/l

0.14

100

822

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS